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Abstract 
As analytical machine learning tools become readily available for clinicians to use, the understanding of key concepts 
and the awareness of analytical pitfalls are increasingly required for clinicians, investigators, reviewers and editors, 
who even as experts in their clinical field, sometimes find themselves insufficiently equipped to evaluate machine 
learning methodologies. In this section, we provide explanations on the general principles of machine learning, as well 
as analytical steps required for successful machine learning-based predictive modelling, which is the focus of this series. 
In particular, we define the terms machine learning, artificial intelligence, as well as supervised and unsupervised 
learning, continuing by introducing optimization, thus, the minimization of an objective error function as the central 
dogma of machine learning. In addition, we discuss why it is important to separate predictive and explanatory 
modelling, and most importantly state that a prediction model should not be used to make inferences. Lastly, we 
broadly describe a classical workflow for training a machine learning model, starting with data pre-processing and 
feature engineering and selection, continuing on with a training structure consisting of a resampling method, 
hyperparameter tuning, and model selection, and ending with evaluation of model discrimination and calibration as 
well as robust internal or external validation of the fully developed model. Methodological rigor and clarity as well as 
understanding of the underlying reasoning of the internal workings of a machine learning approach are required, 
otherwise predictive applications despite being strong analytical tools are not well accepted into the clinical routine.  
 
 
Keywords: machine learning, clinical prediction model, prediction, prognosis, machine intelligence, artificial 
intelligence
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Introduction 
For millennia, the fascination with predicting the 
future has intrigued humanity. In medicine, numerous 
risk stratification scores such as the CURB-65 score for 
mortality risk in community-acquired pneumonia[31], 
the CHA₂DS₂-VASc Score for stroke risk in atrial 
fibrillation[32], or the modified Fisher scale for 
vasospasm risk after subarachnoid hemorrhage[15] are 
used on a daily basis to forecast future events. These 
risk classification schemes allow stratification of 
patients into different, broad risk groups - although 
they are often quite limited in their predictive 
performance and do not allow personalized predictions 
for an individual patient. In trying to predict the 
future, medical professionals are essentially attempting 
the impossible, as the vast majority of outcomes of 
interest in clinical medicine are governed by countless 
minute variables, so that any prediction will always 
remain only a model of reality, and can take into 
account only so many factors. This is also evident in 
the sometimes poor accuracy of 
outcome predictions, often massively underestimating 
the likelihood of adverse events [36, 39, 40].  
Advances in both statistical modeling techniques as 
well as in computing power over the last few decades 
have enabled the rapid rise of the field of data science, 
including artificial intelligence (AI) and machine 
learning (ML) [27]. Along with the broader application 
of epidemiological principles and larger sample sizes 
, this has led to broad adoption of 
statistical prediction modelling in clinical practice and 
research. Clinical prediction models integrate a range 
of input variables to predict a specific outcome in the 
future and can aid in evidence-based decision-making 
and improved patient counseling [35, 41]. Even in the 
field of neurosurgery, ML has been increasingly applied 
over the years, as evidenced by the sharp rise in 
publications on machine learning and neurosurgery 
indexed in PubMed / MEDLINE since the 2000s 
(Figure 1). While the history of ML applications to 
the field of neurosurgery is rather compressed into the 
past two decades, some early efforts have been made 
as early as the late 1980s. Disregarding other uses of 
AI and ML  such as advanced histopathological or 
radiological diagnostics  and focusing on predictive 
analytics, in 1989 Mathew et al.[33] published a report 
in which they applied a fuzzy logic classifier to 150 
patients, and were able to predict whether disc 
prolapse or bony nerve entrapment were present based 
on clinical findings. In 1998, Grigsby et al.[19] were 
able to predict seizure freedom after anterior temporal 
lobectomy using neural networks based on EEG and 
MRI features, using data from 87 patients. Similarly, 
in 1999, Arle et al. [4] applied neural networks to 80 
patients to predict seizures after epilepsy surgery. 
Soon, and especially since 2010, a multitude of 
publications followed, applying ML to clinical outcome 
prediction in all subspecialties of the neurosurgical 
field [6, 43, 44]. While clinical prediction modeling has 
certainly been the by far most common application of 
machine learning in neurosurgery, other exciting 
applications in neurosurgery such as e.g. in image 
recognition [49, 52], natural language processing [42], 
radiomic feature extraction [12, 25], EEG classification 
[53], and continuous data monitoring [41] should not 
be disregarded.  
Today, ML and other statistical learning techniques 
have become so easily accessible to anyone with a 
computer and internet access, that it has become of 
Figure 1 
 * Projected data 
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paramount importance to ensure correct methodology. 
Moreover, th
terms ML and AI in recent years. Because of their 
present-day low threshold to accessibility, these 
techniques can easily be misused and misinterpreted, 
without intent to do so. For example, it is still common 
to see highly complex and data-hungry algorithms 
such as deep neural networks applied to very small 
datasets, to see overtly overfitted or imbalanced 
models, or to see models trained for prediction that are 
identify  (explanation or 
inference). Especially in clinical practice and in the 
medicolegal arena, it is vital that clinical prediction 
models intended to be implemented into clinical 
practice are developed with methodological rigor, and 
that they are well-validated and generalizable. This 
series aims to bring the general principles of ML for 
clinical outcome prediction closer to clinical 
neuroscientists, and to provide a practical approach to 
classification and regression problems that the reader 
may apply to their own research. At this point, it is 
important to stress that the concepts and methods 
presented herein are intended as an entry-level guide 
to ML for clinical outcome prediction, presenting one 
of many valid approaches to clinical prediction 
modeling, and thus does not encompass all the details 
and intricacies of the field. Further reading is 
recommended, including but not limited to Max 
 [28] and Ewout 
 [48]. 
This first part focuses on defining the terms ML and 
AI in the context of predictive analytics, and clearly 
describing their applications in clinical medicine. In 
addition, some of the basic concepts of machine 
intelligence are discussed and explained. Part II goes 
into detail about common problems when developing 
clinical prediction models: What overfitting is and how 
to avoid it to arrive at generalizable models, how to 
select which input features are to be included in the 
final model (feature selection) or how to simplify 
highly dimensional data (feature reduction). We also 
discuss how data splits and resampling methods like 
cross-validation and the bootstrap can be applied to 
validate models before clinical use. Part III touches on 
several topics including how to prepare your data 
correctly (standardization, one-hot encoding) and 
evaluate models in terms of discrimination and 
calibration, and points out some recalibration 
methods. Some other points of significance and caveats 
that the reader may encounter while developing a 
clinical prediction model are discussed: sample size, 
class imbalance, missing data and how to impute it, 
extrapolation, as well as how to choose a cutoff for 
binary classification. Parts IV and V present a 
practical approach to classification and regression 
problems, respectively. They contain detailed 
instructions along with a downloadable code for the R 
statistical programming language, as well as a 
simulated database of Glioblastoma patients that 
allows the reader to code in parallel to the 
explanations. This section is intended as a scaffold 
upon which readers can build their own clinical 
prediction models, and that can easily be modified. 
Furthermore, we will not in detail explain the workings 
of specific ML algorithms such as generalized linear 
models, support vector machines, neural networks, or 
stochastic gradient boosting. While it is certainly 
important to have a basic understanding of the specific 
algorithms one applies, these details can be looked up 
online [37] and detailed explanations of these 
algorithms would go beyond the scope of this guide. 
The goal is instead to convey the basic concepts of ML-
based predictive modeling, and how to practically 
implement these. 
 
Machine Learning - Definitions 
As a field of study, ML in medicine is positioned 
between statistical learning and advanced computer 
science, and typically evolves around learning 
problems, which can be conceptually defined as 
optimizing a performance measure on a given task by 
learning through training experience on prior data. A 
ML algorithm inductively learns to automatically 
extract patterns from data to generate insights [21, 24] 
without being explicitly programmed. This makes ML 
an attractive option to predict even complex 
phenomena without pre-specifying an a-priori 
theoretical model. ML can be used to leverage the full 
granularity of the data richness enclosed in the Big 
Data trend.  Both the complexity and dimensionality 
of modern medical data sets are constantly increasing 
and nowadays comprise many variables per 
observation, much so that we speak  
with generally more variables (in ML lingo called 
features) than observations (samples) [22, 51]. This has 
given rise to the so- omics including 
radiomics and genomics [2, 30, 50]. The sheer 
complexity and volume of data ranging from hundreds 
to thousands of variables at times exceeds human 
comprehension, but combined with increased 
computational power enables the full potential of 
ML.[37, 54].  
With the exponential demand of AI and ML in modern 
medicine, a lot of confusion was introduced regarding 
the separation of these two terms. AI and ML are 
frequently used interchangeably. We define ML as 
subset of AI  to quote Tom Mitchell  M is the 
study of computer algorithms that allow computer 
programs to automatically improve through 
 [34], 
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discussed earlier.  In contrast, AI is philosophically 
much vaster, and can be defined as an ambition to 
enable computer programs to behave in a human-like 
nature. That is, showing a certain human-like 
intelligence. In ML, we learn and optimize a an 
algorithm from data for maximum performance on a 
certain learning task. In AI, we try to emulate natural 
intelligence, to not only learn but apply the gained 
knowledge to make elaborate decisions and solve 
complex problems. In a way, ML can thus be 
considered a technique towards realizing (narrow) AI. 
Ethical considerations on  far-
reaching [26, 46], while the concept of a clinician aided 
by ML-based tools is well-accepted.  
The most widely used ML methods are either 
supervised or unsupervised learning methods, with the 
exceptions of semi-supervised methods and 
reinforcement learning [19, 22]. In supervised learning, 
a set of input variables are used as training set, e.g. 
different meaningful variables such as age, gender, 
tumour grading, or functional neurological status to 
predict a known target variable , e.g. overall 
survival. The ML method can then learn the pattern 
linking input features to target variable, and based on 
that enable the prediction of new data points  hence, 
generalize patterns beyond the present data.  We can 
train a ML model for survival prediction based on a 
retrospective cohort of brain tumour patients, since we 
know the individual length of survival for each patient 
of the cohort. Therefore, the target variable is labelled, 
and the machine learning-paradigm supervised. Again, 
the actually chosen methods can vary: Common 
models include support vector machines (SVMs), as 
example of a parametric approach, or the k-nearest 
neighbour (KNN) algorithm as a nonparametric 
method [11]. On the other hand, in unsupervised 
learning, we generally deal with unlabelled data with 
the assumption of the structural coherence. This can 
be leveraged in clustering, which is a subset of 
unsupervised learning encompassing many different 
methods, e.g. hierarchical clustering or k-means 
clustering [3, 21]. The observed data is partitioned into 
clusters based on a measure of similarity regarding the 
structural architecture of the data. Similarly, 
dimensionality reduction methods  including 
principal component analysis (PCA) or autoencoders -  
can be applied to derive a low-dimensional 
representation explicitly from the present data [21, 35]. 
A multitude of diverse ML algorithms exist, and 
algorithm for a given 
application can be quite confusing. Moreover, based on 
the so-called no free lunch theorem [56] no single 
statistical algorithm or model can generally be 
considered superior for all circumstances. Nevertheless, 
ML algorithms can vary greatly based on the (a) 
representation of the candidate algorithm, (b) the 
selected performance metric and (c) the applied 
optimization strategy[14, 21, 24].  Representation 
formally deal with the problem at hand. This includes 
but is not limited to instance-based learners, such as 
KNN, which instead of performing explicit 
generalization compares new observations with similar 
instances observed during training.[5] Other 
representation spaces include hyperplane-based 
models, such as logistic regression or naïve Bayes, as 
well as rule-based learners, decision trees or complex 
neural networks, all of which are frequently leveraged 
in various ML problems across the neurosurgical 
literature[9, 43]. The evaluated performance metrics 
can vary greatly, too. Performance evaluation and 
reporting play a pivotal role in predictive analytics (c.f. 
Part III). Lastly, the applied ML algorithm is 
optimized by a so-called objective function such as 
greedy search or unconstrained continuous 
optimization options, including different choices of 
gradient descent [7, 38]. Gradient descent represents 
the most common optimization strategy for neural 
networks and can take different forms, e.g.  batch- 
, stochastic- or mini-batch gradient 
descent[38]. We delve deeper into optimization to 
illustrate how it is used in learning. 
 
Optimization  The Central Dogma of Learning 
Techniques 
At the heart of nearly all ML and statistical modeling 
techniques used in data science lies the concept of 
optimization. Even though optimization is the 
backbone of algorithms ranging from linear and logistic 
regression to neural networks, it is not often stressed 
in the non-academic data science space. Optimization 
describes the process of iteratively adjusting 
parameters to improve performance. Every 
optimization problem can be decomposed into three 
basic elements: First, every algorithm has parameters 
(sometimes called weights) that govern how the values 
of the input variables lead to a prediction. In linear 
and logistic regression for example, these parameters 
include the coefficients that are multiplied with the 
input variable values, as well as the intercept. Second, 
there may be realistic constraints within which the 
parameters, or their combinations, must fall. While 
simple models such as linear and logistic regression 
often do not have such constraints, other ML 
algorithms such as support vector machines or k-means 
clustering do. Lastly and importantly, the 
optimization process is steered by evaluating a so-
called objective function that assesses how well the 
current iteration of the algorithm is performing. 
Commonly, these objective functions are error (also 
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called loss) functions, describing the deviation of the 
predicted values from the true values that are to be 
predicted. Thus, these error functions must be 
minimized. Sometimes, you may choose to use 
indicators of performance, such as accuracy, which 
conversely need to be maximized throughout the 
optimization process. 
The optimization process starts by randomly 
initializing all model parameters  that is, assigning 
some initial value for each parameter. Then, 
predictions are made on the training data, and the 
error is calculated. Subsequently, the parameters are 
adjusted in a certain direction, and the error function 
is evaluated again. If the error increases, it is likely 
that the direction of adjustment of the parameters was 
awry and thus led to a higher error on the training 
data. In that case, the parameter values are adjusted 
in different directions, and the error function is 
evaluated again. Should the error decrease, the 
parameter values will be further modified in these 
specific directions, until a minimum of the error 
function is reached. The goal of the optimization 
process is to reach the global minimum of the error 
function, that is, the lowest error that can be achieved 
through the combination of parameter values within 
their constraints. However, the optimization algorithm 
must avoid getting stuck at local minima of the error 
function (see Figure 2).  
The way in which the parameters are adjusted after 
each iteration is governed by an optimization 
algorithm, and approaches can differ greatly. For 
example, linear regression usually uses the ordinary 
least square (OLS) optimization method. In OLS, the 
parameters are estimated by solving an equation for 
the minimum of the sum of the square errors. On the 
other hand, stochastic gradient descent  which is a 
common optimization method for many ML 
algorithms  iteratively adjusts parameters as 
described above and as illustrated in Figure 2. In 
stochastic gradient descent, the amount by which the 
parameters are changed after each iteration (also 
called epoch) is controlled by the calculated derivative 
(i.e. the slope or gradient) for each parameter with 
respect to the error function, and the learning rate. In 
many models, the learning rate is an important 
hyperparameter to set, as it controls how much 
parameters change in each iteration.  
 
Classical/Inferential Statistics Statistical/Machine Learning 
Explanatory modeling 
An a priori chosen theoretical model is applied to data 
in order to test for causal hypotheses. 
Predictive modeling 
The process of applying a statistical model or data 
mining algorithm to data for the purpose of predicting 
new or future observations. 
Focus on in-sample estimates 
Goal: to confirm the existence of an effect in the entire 
data sample. Often using significance testing. 
Focus on out-of-sample estimates 
Goal: Use the best performing model to make new 
prediction for single new observations. Often using 
resampling techniques. 
Focus on model interpretability 
The model is chosen apriori, while models with intrinsic 
means of interpretability are preferred, e.g. a GLM, 
often parametric with a few fixed parameters. 
Focus on model performance 
Different models are applied and the best performing one 
is selected. Models tend to be more flexible and 
expressive, often non-parametric with many parameters 
adapting to the present data. 
Experimental data Empirical data 
Long data (n samples > p variables) Wide data (n samples << p variables) 
Independent variables Features 
Dependent variable Target variable 
Learn deductively by model testing Learn a model from data inductively 
Figure 2 Illustration of an optimization problem. In the x and z dimension, two 
parameters can take different values. In the y dimension, the error is displayed 
for different values of these two parameters. The goal of the optimization 
algorithm is to reach the global minimum (A) of the error through adjusting the 
parameter values, without getting stuck at a local minimum (B). In this example, 
three models are initialized with different parameter values. Two of the models 
converge at the global minimum (A), while one model gets stuck at a local 
minimum (B). Illustration by Jacopo Bertolotti. This illustration has been made 
available under the Creative Commons CC0 1.0 Universal Public Domain 
Dedication. 
 
Table 1 A comparison of central concepts in classical / inferential statistics versus in statistical / machine learning. 
Kernbach & Staartjes Machine learning-based clinical prediction modeling Part I 
6 
 
On the one hand, small learning rates can take many 
iterations to converge and make getting stuck at a 
local minimum more likely  on the other hand, a large 
learning rate can overshoot the global minimum. As a 
detailed discussion of the mathematical nature behind 
different algorithms remains beyond the scope of this 
introductory series, we refer to popular standard 
by Hastie and Tibshirani [21]
Goodfellow et al. [17] achine 
[47] 
 
Explanatory Modeling versus Predictive 
Modeling 
ML has generated a 
methodological shift from classical statistics 
(experimental setting, hypothesis testing, group 
comparison, inference) to data-driven statistical 
learning (empirical setting, algorithmic modeling 
comprising ML, AI, pattern recognition).[18] 
Unfortunately, the two statistical cultures have 
developed separately over the past decades [8] leading 
to incongruent evolved terminology and 
misunderstandings in the absence of an agreed-upon 
technical theorem (Table 1). This already becomes 
evident in the basic terminology describing model 
inputs and outputs: predictors or independent 
variables refer to model inputs in classical statistics, 
while features are the commonly used term in ML; 
outputs, known as dependent variable or response, are 
often labeled target variable or label in ML instead [10]. 
The duality of language has led to misconceptions 
regarding the fundamental difference between 
inference and prediction, as the term prediction has 
frequently been used incompatibly as in-sample 
correlation instead of out-of-sample generalization [16, 
45]. The variation of one variable with a subsequent 
correlated variable later in time, such as the outcome, 
in the same group (in-sample correlation) does not 
imply prediction, and failure to account for this 
distinction can lead to false clinical decision 
making[55, 57]. Strong associations between variables 
and outcome in a clinical study remain averaged 
estimates of the evaluated patient cohort, which does 
not necessarily enable predictions in unseen new 
patients. To shield clinicians from making wrong 
interpretations, we clarify the difference between 
explanatory modeling and predictive modeling, and 
highlight the potential of ML for strong predictive 
models.  
Knowledge generation in clinical research has nearly 
exclusively been dominated by classical statistics with 
the focus on explanatory modeling (EM)[45]. In 
carefully designed experiments or clinical studies, a 
constructed theoretical model, e.g. a regression model, 
is applied to data in order to test for causal hypotheses. 
Based on theory,  a model is chosen a priori, combining 
a fixed number of experimental variables, which are 
under the control of the investigator. Explicit model 
assumptions such as the gaussian distribution 
assumption are made, and the model, which is believed 
to represent the true data generating process, is 
evaluated for the entire present data sample based on 
hypothesis and significance testing . In 
such association-based modeling, a set of independent 
variables (X) are assumed to behave according to a 
certain mechanism and ultimately cause an 
effect measured by the dependent variable (Y). Indeed, 
the role of theory in explanatory modeling is strong 
and is always reflected in the applied model, with the 
aim to obtain the most accurate representation of the 
underlying theory (technically speaking, classical 
statistics seeks to minimize bias). Whether theory 
holds true and the effect actually exists is then 
confirmed in the data, hence the overall analytical goal 
is inference.  
Machine learning-based predictive modeling (PM) is 
defined as the process of applying a statistical model 
or data mining algorithm to data for the purpose of 
predicting future observations. In a heuristic approach, 
ML or PM is applied to empirical data as opposed to 
experimentally controlled data.  
 
As the name implies, the primary focus lays on 
optimizing the prediction of a target variable (Y) for 
new observations given their set of features (X). As 
opposed to explanatory modeling, PM is forward 
looking[45] with the intention of predicting new 
observations, and hence generalization beyond the 
present data is the fundamental goal of the analysis. 
In contrast to EM, PM seeks to minimize both 
variance and bias[13, 23], occasionally sacrificing the 
theoretical interpretability for enhanced predictive 
power. Any underlying method can constitute a 
predictive model ranging from parametric and rigid 
models to highly flexible non-parametric and complex 
models. With a minimum of a-priori specifications, a 
model is then heuristically derived from the data[1, 29]. 
The true data generating process lays in the data, and 
is inductively learned and approximated by ML 
models.   
 
Workflow for Predictive Modeling 
In clinical predictive analytics, generalization is our 
ultimate goal. To answer different research objectives, 
we develop, test and evaluate different models for the 
purpose of clinical application (for an overview see 
https://topepo.github.io/caret/available-
models.html). Many research objectives in PM can be 
framed either as the prediction of a continuous 
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endpoint (regression) such as progression-free survival 
measured in months or alternatively as the prediction 
of a binary endpoint. (classification), e.g. survival after 
12 months as a dichotomized binary. Most continuous 
variables can easily be reduced and dichotomized into 
binary variables, but as a result data granularity is 
lost. Both regression and classification share a common 
analytical workflow with difference in regard to model 
evaluation and reporting (c.f. Part IV Classification 
problems and V Regression problems for a detailed 
discussion). An adaptable pipeline for both regression 
and classification problems is demonstrated in Part IV 
and V. Both sections contain detailed instructions 
along with a simulated dataset of 10 000 patients with 
glioblastoma and the code based on the statistical 
programming language R, which is available as open-
source software. 
For a general overview, a four-step approach to PM is 
proposed (Figure 3): First and most important (1) all 
data needs to be pre-processed. ML is often thought of 
as letting data do the heavy lifting, which in part is 
correct, however the raw data is often not suited to 
learning well in its current form. A lot of work needs 
to be allocated to preparing the input data including 
data cleaning and pre-processing (imputation, scaling, 
normalization, encoding) as well as feature engineering 
and selection. This is followed by using (2) resampling 
techniques such as k-fold cross validation (c.f. Part II: 
generalization and overfitting) to train different 
models and perform hyperparameter tuning. In a third 
step (3), the different models are compared and 
evaluated for generalizability based on a chosen out-
of-sample performance measure in an independent 
testing set. The best performing model is ultimately 
-of-sample calibration assessed 
(c.f. Part III: Evaluation and points of significance), 
and, in a fourth step (4) the model is externally 
validated  or at least prospectively internally 
validated  to ensure clinical usage is safe and 
generalizable across locations, different populations 
and end users (c.f. Part II Generalization and 
overfitting). The European Union (EU) and the Food 
and Drug Administration (FDA) have both set 
standards for classifying machine learning and other 
software for use in healthcare, upon which the 
extensiveness of validation that is required before 
approved introduction into clinical practice is based. 
For example, to receive the CE mark for a clinical 
decision support (CDS) algorithm  depending on 
classification   the EU requires compliance with ISO 
13485 standards, as well as a clinical evaluation report 
(CER) that includes a literature review and clinical 
testing (validation).[20] 
 
Conclusion 
We appear to be at the beginning of an accelerated 
trend towards data-driven decision-making in 
biomedicine enabled by a transformative technology  
machine learning [24]. Given the ever-growing and 
highly complex biomedical datasets and 
increases in computational power, machine learning 
approaches prove to be highly successful analytical 
strategies towards a patient-tailored approach 
regarding diagnosis, treatment choice and outcome 
prediction. Going forward, we expect that training 
neuroscientists and clinicians in the concepts of 
machine learning will undoubtably be a corner stone 
for the advancement of individualized medicine in the 
Figure 3 A four-step predictive modeling workflow. (1) Data preparation includes cleaning and featurization of the given raw data. Data pre-
processing combines cleaning and outlier detection, missing data imputation, the use of standardization methods, and correct feature encoding. The 
pre-processed data is further formed into features  manually in a process called feature engineering or automatically deduced by a process called 
feature extraction.  In the training process (2) resampling techniques such as k-fold cross validation are used to train and tune different models. 
Most predictive features are identified in a feature selection process. (3) Models are compared and evaluated for generalizability in an independent 
testing set. The best performing model is selected, and out-of-sample discrimination and calibration are assessed. (4) The generalizing model is 
prospectively internally and externally validated to ensure safe clinical usage across locations and users. 
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realm of precision medicine. With the series Machine 
learning-based clinical prediction modeling , we aim to 
provide both a conceptual and practical guideline for 
predictive analytics in the clinical routine to 
machine learning techniques.  
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Abstract 
In this section, we review the concept of overfitting, which is a well-known concern within the machine learning 
community, but less established in the clinical community. Overfitted models may lead to inadequate conclusions that 
may wrongly or even harmfully shape clinical decision- making. Overfitting can be defined as the difference among 
discriminatory training and testing performance - while it is normal that out-of-sample performance is equal to or ever 
so slightly worse than training performance for any adequately fitted model, a massive worse out-of-sample 
performance suggests relevant overfitting. As strategies to combat overfitting, we delve into resampling methods, and 
specifically recommend the use of k-fold cross validation and the bootstrap to arrive at realistic estimates of out-of-
sample error during training. Also, we encourage the use of regularization techniques such as L1 or L2 regularization, 
and to choose an appropriate level of algorithm complexity for the type of dataset used. To further prevent overfitting, 
the concept of data leakage or data contamination is addressed - when information about the test data leaks into the 
training data. Also, the importance of external validation to assess true out-of-sample performance and to - upon 
successful external validation - release the model into clinical practice is discussed. Finally, for highly dimensional 
datasets, the concepts of feature reduction using principal component analysis (PCA) as well as feature elimination 
using recursive feature elimination (RFE) are elucidated. 
 
 
Keywords: machine learning; clinical prediction model; prediction; prognosis; machine intelligence; artificial 
intelligence 
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Introduction 
In the first part of this review series, we have discussed 
general and important concepts of machine learning 
(ML) and presented a four-step workflow for machine 
learning-based predictive pipelines. However, many 
regularly faced challenges, which are well-known 
within the ML community, are less established in the 
clinical community. One common source of trouble is 
overfitting. It is a common pitfall in predictive 
modelling, whereby the model not only fits the true 
underlying relationship of the data but also fits the 
individual biological or procedural noise associated 
with each observation. Dealing with overfitting 
remains challenging in both regression and 
classification problems. Erroneous pipelines or ill-
suited applied models may lead to drastically inflated 
model performance, and ultimately cause unreliable 
and potentially harmful clinical conclusions. We 
discuss and illustrate different strategies to address 
overfitting in our analyses including resampling 
methods, regularization and penalization of model 
complexity [7]. In addition, we discuss feature selection 
and feature reduction. In this section, we review  
 
 
overfitting as potential danger in predictive analytic 
strategies with the goal of providing useful 
recommendations for clinicians to avoid flawed 
methodologies and conclusions (Table 1).  
 
 
Overfitting 
Overfitting occurs when a given model adjusts too 
closely to the training data, and subsequently 
demonstrates poor performance on the testing data 
(Figure 1). While the of fit to the 
present data sample seems impressive, the model will 
be unable to make accurate predictions on new 
observations. This scenario represents a major pitfall 
in ML. At first, the performance within the training 
data seems excellent
performance is evaluated on the hold-out data -
of- it generalizes poorly. There are 
various causes of overfitting, some of which are 
intuitive and easily mitigated. Conceptually, the 
easiest way to overfit is simply by memorizing 
observations [2, 17, 33].  
Concept Explanation 
Noise Noise is unexplained and random variation inherent to the data (biological noise) or introduced by 
variables of no interest (procedural noise, including measurement errors, site variation). 
Overfitting Over-learning of random patterns associated with noise or memorization in the training data. Overfitting 
leads to a drastically decreased ability to generalize to new observations.  
Bias Bias quantifies the error term introduced by approximating highly complicated real-life problems by a 
much simpler statistical model. Models with high bias tend to underfit. 
Variance Variance refers to learning random structure irresponsible of the underlying true signal.  Models with high 
variance tend to overfit. 
Data Leakage / Contamination Or the concept of 
also re-
association. 
Model Selection Iterative process using resampling such as k-fold cross-validation to fit different models in the training set. 
Model Assessment -of-sample performance. This should be conducted on a test set of data that 
was set aside and not used in training or model selection. The use of multiple measures of performance 
(AUC, F1 etc.) are recommended.  
Resampling Resampling methods fit a model multiple times on different subsets of the training data. Popular methods 
are k-fold cross-validation and the bootstrap. 
K-Fold Cross Validation Data is divided in k equally sized folds/sets. Iteratively, k-1 data is used for training and evaluated on the 
remaining unseen fold. Each fold is used for testing once. 
LOOCV LOOCV (leave-one-out cross validation) is a variation of cross-validation. Each observation is left out 
once, the model is trained on the remaining data, and then evaluated on the held-out observation.  
Bootstrap The bootstrap allows to estimate the uncertainty associated with any given model. Typically, in 1000-
10000 iterations bootstrapped samples are repetitively drawn with replacement from the original data, the 
predictive model is iteratively fit and evaluated.  
Hyperparameter Tuning Hyperparameters define how a statistical model learns and need to be specified before training. They are 
number of trees and their depth (random forest), and many more. Hyperparameters can be tuned, that is, 
iteratively improved to find the model that performs best given the complexity of the available data.  
Table 1 Concept summaries. 
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We simply remember all data patterns, important 
patterns as well as unimportant ones. For our 
training data, we will get an exceptional model fit, 
and minimal training error by recalling the known 
observations from memory  implying the illusion of 
success. However, o
performance on independent test data, we will 
observe predictive performance that is no better than 
random.  By over-training on the present data, we 
end up with a too close fit to the training 
observations. This fit only partially reflects the 
underlying true data-generating process, but also 
includes random noise specific to the training data. 
This can either be sample-specific noise, both 
procedural as well as biological, but also the 
hallucination of unimportant patterns [9]. Appling 
the overfitted model to new observations will out 
itself as a out-of-sample performance that is 
massively worse than the training performance. In 
this way, the amount of overfitting can be defined as 
the difference among discriminatory training and 
testing performance  while it is normal that out-of-
sample performance is equal to or ever so slightly 
worse than training performance for any adequately 
fitted model, a massive difference suggests relevant 
overfitting. This is one reason why in-sample model 
performance should never be reported as evidence for 
predictive performance. Instead model training and 
selection should always be performed on a separate 
train set, and only in the final step should the final 
model be evaluated on an independent test set to judge 
true out-of-sample performance.  
 
The Bias-Variance Trade-Off 
In ML we opt to make accurate and generalizable 
predictions. When the test error is significantly higher 
than the training error, we can diagnose overfitting. 
To understand what is going on we can decompose the 
predictive error into its essential parts bias and 
variance [8, 19]. Their competing nature, commonly 
known under the term bias-variance trade-off, is very 
important and notoriously famous in the machine 
learning community. Despite its fame and importance, 
the concept is less prominent within the clinical 
community. Bias quantifies the error term introduced 
by approximating highly complicated real-life 
problems by a much simpler statistical model, that is 
underfitting the complexity of the data-generating 
process. In other words, a model with high bias tends 
to consistently learn the wrong response. That by itself 
does not necessarily need to be a problem, as simple 
models were often found to perform very well 
sometimes even better than more sophisticated ones 
[16]. However, for maximal predictive compacity we 
need to find the perfect balance between bias and 
variance. The term variance refers to learning random 
structure irresponsible of the underlying true signal.  
That is, models with high variance can hallucinate 
patterns that are not given by the reality of the data. 
Figure 1 illustrates this in a classification problem. A 
linear model (Figure 1A, high bias and low variance) 
applied to class data, in which the frontier between the 
two classes is not a hyperplane, is unable to induce the 
underlying true boundary. It will consistently learn the 
wrong response, that is a hyperplane, despite the more 
complex true decision boundary and result into 
-generating process. On the 
other extreme, an excessively flexible model with high 
variance and low bias (Figure 1C) will learn random 
non-predictive structure that is unrelated to the 
underlying signal. Given minimally different 
observations, the overly flexible model fit could 
drastically change in an instance.  The latter complex 
model would adapt well to all training observations 
but would ultimately fail to generalize and predict new 
observations in an independent test set. Neither the 
Figure 1 Conceptual visualization of the bias-variance trade-off. A 
predictive model with high bias and low variance (A), consistently 
approximates the underlying data-generating process with a much simpler 
model (here a hyperplane), and hence result in an underfit solution. (B) A 
U-shaped decision boundary represents the optimal solution in this scenario, 
here, both bias and variance are low, resulting in the lowest test error. (C) 
Applying an overly flexible model results in overfitting. Data quirks and 
random non-predictive structures that are unrelated to the underlying 
signal are learned 
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extremely flexible nor the insufficiently flexible model 
is capable of generalizing to new observations.  
 
Combatting Overfitting: Resampling 
We could potentially collect more data for an 
independent cohort to test our model, but this would 
be highly time-consuming and expensive. In rich data 
situations, we can alternatively split our sample into a 
data set for training and a second set for testing (or 
hold-out set) to evaluate the 
new data -of-sample performance) 
more honestly. We would typically use a random 
80%/20% split for training and testing (while 
remaining class balance within the training set, c.f. 
Part III). Because we often lack a sufficiently large 
cohort of patients to simply evaluate generalization 
performance using data splits, we need to use a less 
data-hungry but equally efficient alternatives. The 
gold standard and popular approach in machine 
learning to address overfitting is to evaluate the 
resampling 
methods.[29] Some of these resampling methods  
particularly the bootstrap  have already long been 
used in inferential statistical analysis to generate 
measures of variance.[6] Resampling methods are an 
include various forms of cross-validation [12, 17]. All 
forms have a common ground: they involve splitting 
the available data iteratively into a non-overlapping 
train and test set. Our statistical model is then refitted 
and tested for each subset of the train and test data to 
obtain an estimate of generalization performance. Most 
modern resampling methods have been derived from 
the jackknife  a resampling technique developed by 
Maurice Quenouille in 1949.[27] The simplest modern 
variation of cross-validation  also based on the 
jackknife  is known as leave-one-out cross-validation 
(LOOCV). In LOOCV, the data (n) is iteratively 
divided into two unequal subsets with the train set of 
n-1 observations and the test set containing the 
remaining one observation. The model is refitted and 
evaluated on the excluded held-out observation. The 
procedure is then repeated n times and the test error 
is then averaged over all iterations. A more popular 
alternative to LOOCV and generally considered the 
gold standard is k-fold cross validation (Figure 2). 
The k-fold approach randomly divides the available 
data into a k amount of nonoverlapping groups, or 
folds, of approximately equal size. Empirically, k=5 or 
k=10 are preferred and commonly used [14]. Each fold 
is selected as test set once, and the model is fitted on 
the remaining k-1 folds. The average over all fold-wise 
performances estimates the generalizability of a given 
statistical model. Within this procedure, importantly, 
no observation is selected for both training and testing. 
This is essential, because, as discussed earlier, 
predicting an observation that was already learned 
during training equals memorization, which in turn 
leads to overfitted conclusions.  
Cross-validation is routinely used in both model 
selection and model assessment. Yet another extremely 
powerful and popular resampling strategy is the 
bootstrap [10, 15], which allows for the estimation of 
statistical method. Here, we obtain new bootstrapped 
sets of data by repeatedly sampling observations from 
the original data set with replacement, which means 
any observation can occur more than once in the 
bootstrapped data sample. Thus, when applying the 
bootstrap, we repeatedly randomly select n patients 
from an n-sized training dataset, and model 
performance is evaluated after every iteration. This 
process is repeated many times - usually with 25 to 
1000 repetitions. 
Considerations on Algorithm Complexity 
To avoid over- or underfitting, an appropriate level of 
model complexity is required.[12, 30] Modulating 
complexity can be achieved by adding a regularization 
term, which can be used with any type of predictive 
model. In that instance, the regularization term is 
added to favour less-complex models with less room to 
overfit. As complexity is intrinsically related to the 
number and magnitude of parameters, we can add a 
regularization or penalty term to control the 
magnitude of the model parameters, or even constrain 
the number of parameters used. There are many 
different penalties specific to selected models. In a 
regression setting, we could add either a L1 penalty 
(LASSO, least absolute shrinkage and selection 
operator), which selectively removes variables form the 
model, a L2 penalty (Ridge or Tikhonov 
regularization), which shrinks the magnitude of 
parameters but never fully removes them from the 
model, or an elastic net (combination of L1 and L2) 
[14, 23, 34]. For neural networks, dropout is a very 
efficient regularization method.[28] Finding the right 
balance based on regularization, that is, to define how 
hyperparameters (L1 or L2 penalty term in regression, 
and many more). Restraining model complexity by 
adding a regularization term is an example of a model 
hyperparameter. Typically, hyperparameters are 
tuned, which means that the optimal level is evaluated 
during model training. Again, it is important to respect 
the distinction of train and test data. As a simple 
guideline, we recommend to automate all necessary 
pre-processing steps including hyperparameter tuning 
within the chosen resampling approach to ensure none 
of the above are performed on the complete data set 
before cross validation [26].  Otherwise, this would 
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result in circularity and inflate the overall predictive 
performance [22]. 
 
 
Data Leakage 
Whenever resampling techniques are applied, the 
investigator has to ensure that data leakage or data 
contamination is not accidently introduced. From the 
standpoint of ML, data contamination  part of the 
test data leaking into the model-fitting procedure  can 
have severe consequences, and lead to drastically 
inflated predictive performance. Therefore, caution 
needs to be allocated to the clean isolation of train and 
test data. As a general rule-of-thumb, no feature 
selection or dimensionality reduction method that 
involves the outcome measure should be performed on 
the complete data set before cross validation or 
splitting. This would open doors for procedural bias, 
and raise concerns regarding model validity. 
Additionally, nested cross validation should be used in 
model selection and hyperparameter tuning. The 
nestedness adds an additional internal cross validation 
 
Usually the data splits are then named train   test  
 (external) validation , however different 
nomenclature is frequently used.  
While resampling techniques can mitigate overfitting, 
they can also lead to manual overfitting when too 
many hyperparameter choices are made in the 
process[25]. Another consideration to keep in mind is 
that whenever a random data split is selected, it is 
with the assumption that each split is representative 
of the full data set. This can become problematic in 
two cases: (1) When data is dependent, data leakage 
occurs when train and test data share non-independent 
observations, such as the inclusion of both the index 
and revision surgery of patients. Both observations are 
systematically similar, induce overfitting and 
ultimately undermine the validity of the resulting 
model performance. (2) When data is not identically 
distributed:  this is a serious problem in small sample 
scenarios, where splits are drawn out of a highly 
variable set of observations. Depending on which of the 
patients end up in the train or test data, the model 
performance can greatly fluctuate, and can be an 
overly optimistic estimate of predictive performance. 
Generally, less inflated predictive performance can be 
observed as the sample size increases [32]. As studies  
Figure 2 K-fold cross validation with an independent holdout set. The complete dataset is portioned into training data (~80%) and testing data (~20%) 
before any resampling is applied. Within the training set, k-fold cross validation is used to randomly divide the available data into k=5 equally sized folds. 
Iteratively, k-1 folds are used to train a chosen model, and the fold-wise performance (Ek) is evaluated on the remaining unseen validation fold. These fold-
wise performances are averaged, and together, the out-of-sample performance is estimated as ETrain. When different models are trained, the best performing 
ETest is reported and estimates the predictive performance beyond the present data. 
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based on small sample sizes can generate highly 
variable estimates, conclusions may often be 
exaggerated or even invalid. Hence, predictive 
modeling should be restricted or used with caution 
when only small amounts of data are available. 
Considerations regarding sample size are discussed in 
Part III. 
 
Importance of External Validation in Clinical 
Prediction Modeling 
External validation of clinical prediction models 
represents an important part in their development and 
rollout [5, 31]. In order to generalize, the input data, 
i.e. the training sample, needs to be representative. 
However, without external validation, the site bias or 
center bias, which includes variations in treatment 
protocols, surgical techniques, level of experience 
between departments and clinical users, as well as the 
so-called sampling/selection bias, which refers to 
systematically different data collection in regard to the 
patient cohort, cannot be detected. For these reasons, 
an empirical assessment of model performance on an 
application can publicly be released. Erroneous or 
biased predictions can have severe sequelae for 
patients and clinicians alike, if misjudgments are made 
based upon such predictions. As a gold standard, 
external validation enables unbiased testing of model 
performance in a new cohort with different 
demographics. If a clinical prediction model shows 
comparable discrimination and calibration 
performance at external validation, generalizability 
may be confirmed. Then, it may be safe to release the 
model into the clinical decision-making progress. As an 
alternative to external validation  certainly the gold 
standard to ensure generalizability of a clinical 
prediction model  one might consider prospective 
internal validation (i.e. validation on a totally new 
sample of patients who are however derived from the 
same center with the same demographics, surgeons, 
and treatment protocols as the originally developed 
model). While prospective internal validation will also 
identify any overfitting that might be present, and will 
enable safe use of the prediction model at that specific 
center, this method does not allow ruling out center 
bias, i.e. does not ensure the safe use of the model in 
other populations. 
 
 
Feature Reduction and Selection 
In overtly complex and high dimensional data with too 
many parameters, we find ourselves in an over-
- a term famously coined by 
Richard Bellmann in 1961 - generalization becomes 
increasingly more difficult in high dimensions. The 
representation of the given feature space [4]. If there 
were too many features or variables present, feature 
reduction or feature selection methods can be applied.  
In feature reduction, methods are applied to simplify 
the complexity of the given high-dimensional data 
while retaining important and innate patterns of the 
data. Principal component analysis (PCA) is a popular 
illustration[24]. As an unsupervised ML method PCA 
is conceptually similar to clustering, and learns from 
data without any reference or a-priori knowledge of the 
predicted outcome. Analytically, PCA reduces high-
dimensional data by projecting them onto the so-called 
principal components, which represent summaries of 
the data in fewer dimensions. PCA can hence be used 
as a strong statistical tool to reduce the main axis of 
variance within a given feature space. Feature 
selection refers to a similar procedure, which is also 
applied to initially too large feature spaces to reduce 
the number of input features. The key in feature 
selection is not to summarize data into lower 
dimensions as in feature reduction, but to actually 
reduce the number of included features to end up with 
  and eliminate all non-
informative ones. Naturally, if certain domain 
knowledge is present, vast sets of features can be 
constructed to a better set of informative features. For 
instance, in brain imaging, voxels of an MRI scan can 
either be considered individually or can be summarized 
into functionally or anatomically homogenous areas  
a concept of topographical segregation that dates back 
to Brodmann[1, 11]. The problem of feature selection 
is well-known in the ML community and has generated 
a vast body of literature early on [3, 21]. A common 
pruning technique to select features that together 
maximize e.g. classification performance is recursive 
feature elimination (RFE)[13, 18]. In RFE, a given 
classifier or regressor is iteratively trained, and a 
ranking criterion for all features is estimated. The 
feature with the smallest respective ranking criterion 
is then eliminated. Introduced by Guyon and 
colleagues [13], RFE was initially used to extract small 
subsets of highly discriminant genes in DNA arrays 
and build reliable cancer classifiers. As an instance of 
backward elimination  that is, we start with the 
complete set of variables and progressively eliminate 
the least informative features  RFE can be used both 
in classification and regression settings with any given 
learner, but remains computationally greedy 
, as many different e.g. classifiers on feature 
subsets of decreasing size are revisited. As an 
important consideration, RFE selects subsets of 
variables based on an optimal subset ranking criterion. 
Consequently, a group of features combined may lead 
to optimal predictive performance, while the individual 
features included do not necessarily have to be the 
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most important. Embedded in the process of model 
training, variable selection procedures such as RFE 
can improve performance by selecting subsets of 
variables that together maximize predictive power. 
Importantly, resampling methods should be applied 
when using RFE to factor in the variability caused by 
feature selection when calculating performance. 
 
Conclusion 
Overfitting is a multifactorial problem, and there are 
just as many possible approaches to reduce its negative 
impact. We encourage the use of resampling methods 
such as cross-validation in every predictive modelling 
pipeline. While there are various options to choose 
from, we recommend the usage of k-fold cross 
validation or the bootstrap. Nested loops may be used 
for hyperparameter tuning and model selection. While 
the use of resampling does not solve overfitting, it 
helps to gain a more representative understanding of 
the predictive performance, especially of out-of-sample 
error. Feature reduction and selection methods, such 
as PCA and RFE are introduced for handling high-
dimensional data. A potential pitfall along the way is 
data contamination, which occurs when data leaks 
from the resampled test to train set and hence leads to 
overconfident model performance. We encourage the 
use of standardized pipelines (see Part IV and V for 
examples), which include feature engineering, 
hyperparameter tuning and model selection within one 
loop to minimize the risk of unintentionally leaking 
test data. Finally, we recommend including a 
regularization term as hyperparameter and to restrict 
extensive model complexity, which will avoid 
overfitted predictive performance.  
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Abstract 
In this section, we touch on the evaluation of clinical classification and regression models, as well as on which metrics 
should be reported when publishing predictive models. First, various available metrics to describe model performance in 
terms of discrimination (area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value, 
negative predictive value, F1 Score) and calibration (slope, intercept, Brier score, expected/observed ratio, Estimated 
Calibration Index, Hosmer-Lemeshow goodness-of-fit) are presented. The concept of recalibration is introduced, with 
Platt scaling and Isotonic regression as proposed methods. We discuss several of the common caveats and other points 
of significance that must be considered when developing a clinical prediction model. As such, we discuss considerations 
regarding the sample size required for optimal training of clinical prediction models - explaining why low sample sizes 
lead to unstable models, and offering the common rule of thumb of at least 10 patients per class per input feature, as 
well as some more nuanced approaches. Missing data treatment and model-based imputation instead of mean, mode, or 
median imputation is also discussed. We explain how data standardization is important in pre-processing, and how it 
can be achieved using e.g. centering and scaling. One-hot encoding is discussed - Categorical features with more than 
two levels must be encoded as multiple features to avoid wrong assumptions. Regarding binary classification models, we 
discuss how to select a sensible predicted probability cutoff for binary classification using the closest-to-(0,1)-criterion 
based on AUC, or based on the clinical question (rule-in or rule-out). Extrapolation is also discussed. 
 
Keywords: machine learning; clinical prediction model; prediction; prognosis; machine intelligence; artificial intelligence
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Introduction 
Once a dataset has been adequately prepared and a 
training structure (e.g. with a resampling method such 
as k-fold cross validation, c.f. Part II) has been set up, 
a model is ready to be trained. Already during training 
and the subsequent model tuning and selection, metrics 
to evaluate model performance become of central 
importance, as the hyperparameters and parameters of 
the models are tuned according to one or multiple of 
these performance metrics. In addition, after a final 
model has been selected based on these metrics, 
internal or external validation should be carried out to 
assess whether the same performance metrics can be 
achieved as during training. This section walks the 
reader through some of the common performance 
metrics to evaluate the discrimination and calibration 
of clinical prediction models based on machine learning 
(ML). We focus on clinical prediction models for 
continuous and binary endpoints, as these are by far 
the most common clinical applications of ML in 
neurosurgery. Multiclass classification  thus, the 
prediction of a categorical endpoint with more than 
two levels  may require other performance metrics.  
Second, when developing a new clinical prediction 
model, there are several caveats and other points of 
significance that the readers should be aware of. These 
include what sample size is necessary for a robust 
model, how to pre-process data correctly, how to 
handle missing data and class imbalance, how to 
choose a cutoff for binary classification, and why 
extrapolation is problematic. In the second part of this 
section, these topics are sequentially discussed.  
 
Evaluation of Classification Models 
The Importance of Discrimination and 
Calibration 
The performance of classification models can roughly 
be judged along two dimensions: Model discrimination 
and calibration.[22] The term discrimination denotes 
the ability of a prediction model to correctly classify 
whether a certain patient is going to or is not going to 
experience a certain outcome. Thus, discrimination 
described the accuracy of a binary prediction  yes or 
no. Calibration, however, describes the degree to which 
% to 
100%) correspond to the actually observed incidence of 
the binary endpoint (true posterior). Many publications 
do not report calibration metrics, although these are of 
central importance, as a well-calibrated predicted 
probability (e.g. your predicted probability of 
experiencing a complication is 18%) is often much more 
valuable to clinicians  and patients!  than a binary 
prediction (e.g. you are likely not going to experience a 
complication).[22] 
 
There are other factors that should be considered when 
selecting models, such as complexity and 
interpretability of the algorithm, how well a model 
calibrates out-of-the-box, as well as e.g. the computing 
power necessary.[7] For instance, choosing an overly 
complex algorithm for relatively simple data (i.e. a 
deep neural network for tabulated medical data) will 
vastly increase the likelihood of overfitting with only 
negligible benefits in performance. Similarly, even 
though discrimination performance may be ever so 
slightly better with a more complex model such as a 
neural network, this comes at the cost of reduced 
[21] The term 
know the input variables are fed into it and the 
predicted outcome, although there is no information on 
the inner workings of the model, i.e. why a certain 
prediction was made for an individual patient and 
which variables were most impactful. This is often the 
case for highly complex models such as deep neural 
networks or gradient boosting machines. For these 
metric that described a ranking of the input variables 
in order of importance can be calculated and should in 
fact be reported. However, how exactly the model 
integrated these inputs and arrived at the prediction 
cannot be comprehended in highly complex models.[21] 
In contrast, simpler ML algorithms, such as generalized 
linear models (GLMs) or generalized additive models 
(GAMs), which often suffice for clinical prediction 
modeling, provide interpretability in the form of odds 
ratios or partial dependence metrics, respectively. 
Lastly, highly complex models often exhibit poorer 
calibration out-of-the-box.[7] 
Consequently, the single final model to be internally or 
externally validated, published, and readied for clinical 
use should not only be chosen based on resampled 
training performance.[23] Instead, the complexity of the 
dataset (i.e. tabulated patient data versus a set of 
DICOM images) should be taken into account. 
Whenever suitable, highly interpretable models such as 
generalized linear models or generalized additive 
models should be used. Overly complex models such as 
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deep neural networks should generally be avoided for 
basic clinical prediction modelling. 
 
Model Discrimination 
For a comprehensive assessment of model 
discrimination, the following data are necessary for 
each patient in the sample: A true outcome (also called 
the predicted probabilities 
produced by the model, and the classification result 
based on that predicted probability (predicted 
outcome). To compare the predicted outcomes and the 
true outcomes, a confusion matrix (Table 1) can be 
generated. Nearly all discrimination metrics can then 
be derived from the confusion matrix. 
 
Area Under The Curve (AUC) 
The only common discrimination metric that cannot be 
derived directly from the confusion matrix is the area 
under the receiver operating characteristic curve 
(AUROC, commonly abbreviated to AUC or ROC, 
also called c-statistic). For AUC, the predicted 
probabilities are instead contrasted with the true 
outcomes. The curve (Figure 1) shows the 
performance of a classification model at all binary 
classification cutoffs, plotting the true positive rate 
(Sensitivity) against the false positive rate (1 - 
Specificity). Lowering the binary classification cutoff 
classifies more patients as positive, thus increasing both 
false positives and true positives. It follows that AUC 
is the only common discrimination metric that is 
uniquely not contingent upon the chosen binary 
classification cutoff. The binary classification cutoff at 
-
to-(0,1)- , can even be used to derive an 
optimal binary classification cutoff, which is explained 
in more detail further on.[15] Models are often trained 
and selected for AUC, as AUC can give a relatively 
value of 1.0 indicates perfect discrimination, while an 
AUC of 0.5 indicates a discriminative performance not 
superior to random prediction. Usually, a model is 
considered to perform well if an AUC of 0.7 or 0.8 is 
achieved. An AUC above 0.9 indicated excellent 
performance.  
 
 Negative Label Positive Label 
Predicted 
Negative 
800 (True Negative) 174 (False 
Negative) 
Predicted 
Positive 
157 (False Positive) 869 (True Positive) 
 
Figure 1 Area under the receiver operating characteristic curve (AUC) 
plot demonstrating an AUC of 0.922. The plot also indicated that, 
-to-(0,1)-
classification cutoff that balances sensitivity and specificity perfectly. 
 
Accuracy 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
𝑇𝑃 + 𝑇𝑁
𝑃 + 𝑁
 
equals the total proportion of patients who were 
correctly classified as either positive or negative cases. 
While accuracy can give a broad overview of model 
performance, it is important to also consider sensitivity 
and specificity, as accuracy can be easily skewed by 
several factors including class imbalance (a caveat 
discussed in detail later on). An accuracy of 100% is 
optimal, while an accuracy of 50% indicates a 
performance that is equal to random predictions. The 
confusion matrix in Table 1 gives an accuracy of 
83.5%. 
 
Sensitivity and Specificity 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =  
𝑇𝑃
𝑃
 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =  
𝑇𝑁
𝑁
 
Sensitivity denotes the proportion of patients who are 
positive cases and who were indeed correctly predicted 
to be positive. Conversely, specificity measures the 
proportion of patients who are negative cases, and who 
were correctly predicted to be negative. Thus, a 
prediction model with high sensitivi ty generates only 
Table 1 A confusion matrix 
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patients if positive, because it produces only few false 
positives. In data science, sensitivity is sometimes 
 The confusion matrix in Table 1 gives a 
sensitivity of 83.3% and a specificity of 83.6%. 
 
Positive Predictive Value (PPV) and Negative 
Predictive Value (NPV) 
𝑃𝑃𝑉 =  
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
 
𝑁𝑃𝑉 =  
𝑇𝑁
𝑇𝑁 + 𝐹𝑁
 
PPV is defined as the proportion of positively 
predicted patients who are indeed true positive cases. 
Conversely, NPV is defined as the proportion of 
negatively predicted patients who turn out to be true 
negatives. PPV and NPV are often said to be more 
easily clinically interpretably in the context of clinical 
prediction modeling than sensitivity and specificity, as 
they relate more directly to the prediction itself: For a 
model with a high PPV, a positive prediction is very 
likely to be correct, and for a model with a high NPV, 
a negative prediction is very likely to be a true 
negative. In data science, PPV is sometimes called 
 The confusion matrix in Table 1 gives a 
PPV of 84.7% and a NPV of 82.1%. 
 
 
F1 Score 
𝐹1 =  2 ×
𝑃𝑃𝑉 × 𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦
𝑃𝑃𝑉 + 𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦
 
The F1 score is a composite metric popular in the ML 
community, which is mathematically defined as the 
harmonic mean of PPV and sensitivity. Higher values 
represent better performance, with a maximum of 1.0. 
The F1 score is also commonly used to train and select 
models during training. The confusion matrix in Table 
1 gives a F1 score of 0.840. 
 
 
Model Calibration 
Calibration Intercept and Slope 
As stated above, calibration describes the degree to 
0%% to 100%) correspond to the actually observed 
incidence of the binary endpoint (true posterior). 
Especially for clinically applied models, a well-
calibrated predicted probability (e.g. your predicted 
probability of experiencing a complication is 18%) is 
often much more valuable to clinicians and patients 
alike than a binary prediction (e.g. you are likely not 
going to experience a complication).[22] A quick 
generating a calibration plot (Figure 2), which we 
recommend to include for every published clinical 
prediction model. In a calibration plot, the patients of 
a certain cohort are stratified into g equally-sized 
groups ranked according to their predicted 
probabilities. If you have a large cohort available, opt 
for g = 10; if you have only few patients you may opt 
for g = 5 to smooth the calibration curve to a certain 
degree. On the y axis, for each of the g groups, the 
observed proportion of positive cases is plotted, while 
the mean predicted probability for each group is 
plotted on the x axis. A model with perfect calibration 
will have a calibration curve closely resembling a 
diagonal line. A poorly calibrated model will deviate in 
some way from the ideal diagonal line, or simply show 
an erratic form. From the predicted probabilities and 
the true posteriors, the two major calibration metrics 
can be derived: Calibration intercept and slope.[25] 
The calibration -in-
the-  A 
perfectly calibrated model has an intercept of 0.00. A 
model with a calibration intercept much larger than 0 
generally puts out too high predicted probabilities and 
thus overestimates the likelihood of a positive outcome. 
Likewise, a model with a negative intercept 
systematically underestimates probabilities. The model 
depicted in Figure 1 sports an intercept of 0.04. 
The calibration slope quantifies the increase of true risk 
 
Figure 2 Calibration plot comparing the predicted probabilities  
divided into ten bins - of a binary classification model to the true 
observed outcome proportions. The diagonal line represents the ideal 
calibration curve. A smoother has been fit over the ten bins. This model 
achieved an excellent calibration intercept of 0.04, with a slope of 0.96. 
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compared to predicted risk. A perfectly calibrated 
model has an intercept of 1.00. If a model has a 
calibration slope that is much larger than 1, the 
increase of the predicted probabilities on the 
calibration curve is too steep, and vice versa. 
 
Brier Score 
The Brier score [3] measures overall calibration and is 
defined as the average squared difference between 
predicted probabilities and true outcomes. It takes on 
values between 0 and 1, with lower values indicating 
better calibration. As a proper scoring rule, the Brier 
score simultaneously captures calibration itself as well 
as sharpness: A property that measures how much 
variation there is in the true probability across 
predictions. When assessing the performance of 
different binary classification models, the Brier score is 
mainly used to compare model performances, and  
being mainly a relative measure  the actual value of 
the score is only of limited value. As a caveat, the 
Brier score only inaccurately measures calibration for 
rare outcomes. 
 
Other Calibration Metrics 
Various other calibration metrics have been developed, 
of which the following three are more commonly used. 
First, the expected/observed ratio, or E/O-ratio, 
describes the overall calibration of a prediction model, 
and is defined as the ratio of expected positive 
(predicted positive) cases and observed positive (true 
positive) cases.[16] A value of 1 is optimal. Second, the 
Estimated Calibration Index (ECI) [27] is a measure of 
overall calibration, and is defined as the average 
squared difference of the predicted probabilities with 
their grouped estimated observed probabilities. It can 
range between 0 and 100, with lower values 
representing better overall calibration. Lastly, the 
Hosmer-Lemeshow goodness-of-fit test can be applied 
to assess calibration, and is based on dividing the 
sample up according to g groups of predicted 
probabilities, with g = 10 being a common value.[8] 
The test then compares the distribution to a chi-square 
distribution. A p > 0.2 is usually seen as an indication 
of a good fit i.e. fair calibration. 
 
Recalibration Techniques 
Should you have arrived at a robustly validated model 
with high performance in discrimination but poor 
calibration, there are several methods available to 
recalibrate the model to fit a population with a 
knowingly different incidence of the endpoint, or to 
even out a consistent deformation of the calibration 
curve.[22] These scenarios are explained in some more 
detail below. Also, if a study reports development of a 
model as well as external validation of that model in a 
different population for which the model is 
recalibrated, both the recalibrated as well as the 
uncalibrated performance of the model in the external 
validation cohort have to be reported, as the 
uncalibrated performance is the only representative and 
unbiased measure of generalizability available. In the 
first case, a model may have been developed in a 
certain country in which the incidence of a certain 
outcome is 10%. If other authors want to apply the 
same exact model in a different country with a known 
incidence of this outcome that is higher at e.g. 20%, 
the model will systematically underestimate predicted 
probabilities  and thus have a negative intercept, 
while maintaining a calibration slope of around 1.0. To 
adjust for the difference in outcome incidence, the 
intercept of the model can be updated to recalibrate 
the model.[9] In the second case, calibration curves 
may consistently show a sigmoid or other reproducible 
deviation from the ideal diagonal calibration curve. 
Two commonly applied methods to improve the 
calibration of the predicted probabilities are logistic 
regression and isotonic regression. Logistic regression 
can be used to train a wrapper model that learns to 
even out the deviation. This technique is called logistic 
recalibration of Platt scaling.[14] Second, isotonic 
regression can be applied to recalibrate the model.[14] 
Isotonic (also called monotonic) regression is a 
nonparametric technique that for fitting a free-form 
line (such as a calibration plot) to a series of reference 
values (such as a perfect diagonal line), under the 
constraints that the fitted line has to be monotonically 
increasing and must lie as close to the reference values 
as feasible.[14] 
It is important to stress here that we recommend 
recalibration only in these two cases listed above: On 
the other hand, if the calibration curve is erratic or a 
deformation of the calibration curve (e.g. sigmoid 
deformation) is not consistent among resamples or 
validation cohorts, we do not recommend recalibration. 
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Evaluation of Regression Models 
For regression problems, performance can only be 
evaluated by comparing the predicted value and the 
true value directly. There are three major performance 
metrics that are used to evaluate the performance of 
regressors: First, root mean square error (RMSE), 
defined as the standard deviation of the differences 
between the predicted and true values (residuals), 
explains the distribution of the residuals around the 
perfect predictions. A perfect RMSE would be 0.00, 
with lower values indicating better performance. 
Similarly, mean absolute error (MAE) measures the 
difference among the predicted and the true values 
directly. Thus, a MAE of 0.00 would indicate no error 
at all, with deviations from 0 indicating overall over- or 
underestimation of values. Lastly, the R2 value, defined 
as the square of the of the correlation coefficient among 
predicted and true values, discloses what proportion of 
the variation in the outcome is explained by the model. 
Consequently, a R2 value of 1.0 would indicate perfect 
explanatory power, and 0.00 would indicate zero 
explanatory power of the model. For regression models, 
a quantile-quantile plot can optionally be included to 
illustrate the relationship among predicted and true 
values over the entire dataset (c.f. Part V). 
 
Points of Significance 
Choosing a Cutoff for Binary Classification  
For binary classifiers which produce predicted 
probabilities, a cutoff (or threshold) has to be set to 
transform the predicted probabilities  ranging from 
0.00 to 1.00  to a binary classification (i.e. yes/no or 
positive/negative or 1/0). While it might be tempting 
and often adequate to simply always use a cutoff of 
0.50 for binary classification, in many cases different 
cutoffs will produce more accurate results in general, 
and the cutoff should also be chosen depending on the 
intended application of a given model.  
 
One quantitative method to calculate a cutoff for 
binary classification that optimizes both sensitivity and 
specificity is the AUC- -to-(0,1)-
[15] Using packages in R such as 
pROC [19], this can be done easily. This technique will 
lead to the most balanced estimation of a binary 
classification cutoff, and can be chosen on a model with 
generally high performance measures that is aimed at 
achieving maximum classification accuracy overall. 
However, in many cases, models are clinically intended 
to rule-in or rule-out critical events. In these cases, the 
binary classification cutoff may be adjusted to achieve 
high specificity or sensitivity, respectively. For 
example, a rule-in model requires a high specificity, 
whereas sensitivity is of secondary importance. In other 
words, if a model with high specificity (> 90%) makes 
a positive prediction, this rules in true case positivity, 
while a negative prediction will have rather little value. 
To increase specificity, the cutoff for binary 
classification can be adjusted upwards (e.g. to 75%). 
positive case. Inversely, a rule-out model will require 
high sensitivity and a negative result to rule out an 
event, in which case the cutoff for binary classification 
can be adjust downwards. Whether a clinical prediction 
model is laid out as a neutral model (cutoff 0.50 or 
-to-(0,1)-criter -in 
model (cutoff adjusted upwards), or rule-in model 
(cutoff adjusted downwards) will depend on the clinical 
question. 
 
Again, it is important to stress at this point that the 
selection of a cutoff for binary classification must occur 
using exclusively training data. Based on the 
(resampled) training performance, a cutoff should be 
chosen using one of the methods described above. Only 
one final, fully trained model and its determined cutoff 
should then be tested on the internal or external 
validation data, which will confirm the generalizability 
of both the model parameters and the cutoff that was 
chosen. If the cutoff is post-hoc adjusted based on the 
internal or external validation data, which are intended 
al-
performance, this evaluation of generalizability 
becomes rather meaningless and generalizability cannot 
be assessed in an unbiased way. Lastly, the threshold 
for binary classification should be reported when 
publishing a clinical prediction model. 
 
Sample Size 
While even the largest cohort with millions of patients 
is not guaranteed to result in a robust clinical 
prediction model if no relevant input variables are 
 do not expect to 
predict the future from age, gender, and body mass 
index), the relationship among predictive performance 
and sample size is certainly directly proportional, 
especially for some data-hungry ML algorithms. To 
ensure generalizability of the clinical prediction model, 
the sample size should be both representative enough 
of the patient population, and should take the 
complexity of the algorithm into account. For instance, 
a deep neural network  as an example of a highly 
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complex model  will often require thousands of 
patients to converge, while a logistic regression model 
may achieve stable results with only a few hundreds of 
patients. In addition, the number of input variables 
plays a role. Roughly, it can be said that a bare 
minimum of 10 positive cases are required per included 
input variable to model the relationships. Often, erratic 
behavior of the models and high variance in 
performance among splits is observed when sample 
sizes are smaller than calculated with this rule of 
thumb. Of central importance is also the proportion of 
patients who experience the outcome. For very rare 
events, a much larger total sample size is 
consequentially needed. For instance, a prediction 
based on 10 input features for an outcome occurring in 
only 10% of cases would require at least 1000 patients 
including at least 100 who experienced the outcome, 
according to the above rule of thumb. In general and 
from personal experience, we do not recommend 
developing ML models on cohorts with less than 100 
positive cases and reasonably more cases in total, 
regardless of the rarity of the outcome. Also, one might 
consider the available literature on risk factors for the 
outcome of interest: If epidemiological studies find only 
weak associations with the outcome, it is likely that 
one will require more patients to arrive at a model with 
good predictive performance, as opposed to an outcome 
which has several highly associated risk factors, which 
may be easier to predict. Larger sample sizes also allow 
for more generous evaluation through a larger amount 
of patient data dedicated to training or validation, and 
usually results in better calibration measures. Lastly, 
some more nuanced and protocolized methods to arrive 
at a sample size have been published, such the Riley et 
size for generating clinical prediction models, which can 
also be consulted.[17, 18]  
 
Standardization 
In clinical predictive modeling, the overall goal is to get 
the best discriminative performance from your ML 
algorithm, and some small steps to optimize your data 
before training may help to increase performance. In 
general, ML algorithms benefit from standardization of 
data, as they may perform more poorly if individual 
features to not appear more or less like normally 
distributed, e.g. representing Gaussian data with a 
mean value of 0 and a variance of 1. While most 
algorithms handle other distributions with ease, some 
(e.g. support vector machines with a radial basis 
function) assume centered and scaled data. If one input 
feature is orders of magnitude larger than all others, 
this feature may predominantly influence predictions 
the other input data. In data science, centering and 
scaling are common methods of standardizing your 
data. To center continuous variables, means are 
subtracted from each value to arrive at a mean of 0. 
Scaling occurs through dividing all variables through 
their standard deviation, after which you end up with z 
scores (the number of standard deviations a value is 
distanced from the mean). As an alternative to this 
standardization approach, data can also be normalized. 
This means that data are rescaled between their 
minimum and maximum (also called Min-Max-Scaling) 
to take on values from 0 to 1, which is particularly 
useful when data do not approximately follow a 
Gaussian distribution, in which case standardization 
based on standard deviations could lead to skewed 
results. Sometimes it can also be advantageous to 
transform i.e. logarithmically distributed variables. 
These steps are well-integrated into R through the 
caret package (c.f. Parts IV and V).[10] There are 
many other methods to pre-process data, which are 
also partially discussed in Part II and below. At this 
point, it is important to stress that all pre-processing 
steps should take place after data splitting into 
training and testing sets, as data leakage can occur (c.f. 
Part II).  
 
One-Hot Encoding 
In many cases, dealing with categorical data as 
opposed to continuous data is challenging in data 
science. Especially when categorical variables are not 
ordinal, handling them similarly to continuous data can 
lead to wrong assumptions as to relationships among 
variables. In addition, some algorithms cannot work 
with categorical data directly and require numerical 
inputs instead, often rather due to their specific 
implementation in statistical programming languages 
like R and not due to a hard mathematical limitations 
of the algorithm itself. Take the 
-
 as an example of a 
non-ordinal feature. In the , the 
encoding of the four levels 
(simple integer encoding) would yield catastrophic 
results, as the four levels would be interpreted as a 
necessar
This may lead to poorer performance and 
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unanticipated results. In addition, any explanatory 
power, such as derived from measures of variables 
importance, will no longer be correct and would lead to 
clinical misinterpretation. 
 
Instead, categorical variables with more than two levels 
should be one-hot encoded. This means that the 
original variable is removed, and that for each unique 
level of this categorical variable, a new dichotomous 
variable is created with  Thus, 
dichotomous variables will be created, namely 
-
forth. One-hot encoding ensures that the influence of 
each individual level of a categorical variable on the 
dependent variable can be accurately represented.  
 
Missing Data and Imputation 
There are also other considerations in pre-processing 
other than centering and scaling, including the 
handling of missing data. In ideal circumstances, we 
would prefer to only work with complete datasets, but 
we are mostly faced with various amount of missing 
values. To deal with missing values is a science on its 
own, which has generated a vast body of literature [12, 
20] and analytical strategies, broadly classified in either 
cases, in which values are missing at random (MAR) or 
completely at random (MCAR), it is safe to discard 
single observations with missing values or even 
complete feature columns when e.g. more than >50% of 
values are systematically missing instead, dropping 
features or observations subsequently introduces bias. 
In this case, imputation might yield better results. 
Strategies can range from simple approaches such as 
mean, mode, or median imputation, which, however, 
defeat the purpose of imputation for clinical prediction 
modeling since they do not factor in correlations 
between variables and do not work well with 
categorical variables, to more complex algorithmic 
imputation techniques. Any applied imputation method 
should however be used with care, and its necessity 
should be carefully considered especially when the 
fraction of missing data is substantial. The best 
approach will always be to keep missing data at a 
minimum. 
 
There are also situations when imputing missing data 
may not be strictly necessary. First, some 
implementations of certain algorithms  for example 
the popular XGBoost [6] implementation of boosted 
decision trees  can handle missing data natively by 
treating empty fields as a unique value. However, the 
majority of algorithms will simply throw out any 
patients with missing data, or impute automatically. 
An additional point to consider is that, while some 
algorithms may be theoretically able to handle missing 
data natively, there is no reason that they should be 
made to do so. One of the cases in which imputing 
data is not strictly necessary is when an abundance of 
data is available with only few fields missing, or when 
data is missing for only a certain few patients  in 
which case it may be more convenient to simply delete 
the missing observations. Deleting larger amounts of 
data  as stated above  is not recommended because it 
may introduce systematic bias. More importantly, 
when data is clearly missing not at random (MNAR), 
imputation and deletion both will lead to inaccurate 
results, and the missingness must be explicitly 
modeled.[13] MNAR occurs when missingness depends 
on specific values of the data, e.g. when there is a 
systematic bias such as when certain populations are 
much less likely to return for follow-up visits due to 
geographical distance, or when obese patients are much 
less likely to report their weight. In cases with data 
that is MNAR, simple imputation will not yield correct 
results. 
 
However, in the majority of cases it is advisable to co-
train an imputer with the actual clinical prediction 
model, even if there is no missing data in the training 
set. This will allow for easy handling of missing data 
that the model may come across in the future, e.g. in 
an external validation set. Again, it is important to 
stress that as with all pre-processing steps, the co-
trained imputer should only ever be trained on the 
training dataset of the prediction model  and should 
never see the validation data. Otherwise, data leakage 
may occur (c.f. Part II). Several simple packages for 
imputation exist in R, including algorithmic imputation 
using the k-nearest neighbour (kNN) algorithm.[26] In 
this approach, the missing datapoint is imputed by the 
average of k nearest neighbouring datapoints based on 
a chosen distance metric. In addition, single imputation 
can be achieved by simple regression models and 
predictive mean matching (PMM).[11] This approach 
works for both continuous and categorical variables, as 
a regressor predicts the missing value from the other 
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available patient data, and then subsequently imputes 
the most closely matching value from the other 
patients without missing values. The advantage here is 
avoidance of imputation of extreme or unrealistic 
values, especially for categorical variables. This 
approach can also be extended to the state-of-the-art of 
multiple imputation through multivariate imputation 
based on chained equasions (MICE) [4], which is harder 
to implement but depicts the uncertainty of the 
missing values more accurately. 
While imputation can be achieved using many different 
algorithms including the methods described, we 
selected the nonparametric kNN method for internal 
consistency in both regression and classification (c.f. 
Parts IV and V) in our practical examples, and because 
there is some evidence that kNN-based imputation may 
outperform some other imputation methods.[1] In 
addition, kNN imputers are highly computationally 
efficient. 
 
Class Imbalance 
Class imbalance is evident when one class - the 
minority class (i.e. patients who experienced a rare 
complication) - is much rarer than the majority class 
(i.e. patients who did not experience this rare 
complication).[24] In clinical neurosciences, class 
imbalance is a common caveat, and many published 
models do not adjust for it. Because ML models extract 
features better and are most robust if all classes are 
approximately equally distributed, it is important to 
know how to diagnose and counteract class imbalance. 
If a considerable amount of class imbalance is present, 
discriminate between classes and instead choose to 
simply vote for the majority class. This bias provides 
synthetically high AUC, accuracy, and specificity. 
However, sensitivity will be near zero, making the 
model unemployable. This 
the situation when synthetically high accuracy only 
reflects the underlying class distribution in unbalanced 
data. For instance, if sensitivity and specificity are not 
reported, class imbalance can still be spotted if the 
model accuracy is virtually identical to the incidence of 
the majority class. In general, if class imbalance is 
present, care should be taken to weight classes or to 
under- or oversample using data science techniques. 
Accuracy and AUC alone do not always give a full 
why reporting a minimum of sensitivity and specificity 
is crucial.[24] 
As an example, one might want to predict 
complications from a cohort containing 90% of patients 
without complications. By largely voting for the 
majority class (no complication), the model would 
achieve an accuracy and specificity of around 90% and 
very low sensitivity without actually learning from the 
data. This can be countered by adjusting class weights 
within the model, by undersampling and thus removing 
observations from the majority class, or by 
oversampling the minority class.[2] Specifically, the 
synthetic minority oversampling technique (SMOTE) 
has been validated, shows robust performance, and is 
easy to employ.[5] SMOTE simulates new observations 
for the minority class by using k-means clustering, thus 
characteristics derived from similar patients already 
present in the dataset. However, conventional 
upsampling  the simple copying of randomly selected 
patients of the minority class until class balance is 
achieved  often works similarly well. When training 
models, the method of handling class imbalance (i.e. 
none, conventional upsampling, or SMOTE) may be 
regarded as a hyperparameter 
 
 
Extrapolation 
The vast majority of ML models are only capable of 
interpolating data  thus, making predictions on cases 
similar to the ones available in the training data  and 
are incapable of extrapolating  making predictions on 
situations that are relevantly different. This can be 
seen similarly to trying to apply the results of a 
randomized controlled drug trial to patients who were 
excluded from the study. For example, a model that 
predicts neurological impairment after brain tumor 
surgery that has been trained and externally validated 
on a large cohort of patients from 30 to 90 years of age 
should not be expected to make accurate predictions 
for pediatric brain tumor patients. Although the goal 
when developing algorithms is generalization to slightly 
other demographics, most algorithms learn to fit the 
training data as closely as possible locally, regardless of 
potential other situations not included in the training 
dataset (c.f. Part II). Thus, caution must be taken 
when making predictions outside the bounds of the 
type of patients included in the training data. Some 
algorithms are considered as being more prone to 
extrapolation errors, such as GAMs based on locally 
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estimated scatterplot smoothing (LOESS) due to their 
reliance on local regression. In conclusion, trained 
models should not be clinically expected to extrapolate 
to patients with vastly differing characteristics. 
 
Conclusion 
Various metrics are available to evaluate the 
performance of clinical prediction models. A suggested 
minimum set of performance metrics includes AUC, 
accuracy, sensitivity, specificity, PPV, and NPV along 
with calibration slope and intercept for classification 
models, or RMSE, MAE, and R2 for regression models. 
These performance metrics can be supplemented by a 
calibration plot or a quantile-quantile plot, 
respectively. Furthermore, there are some common 
caveats when developing clinical prediction models that 
readers should be aware of: Sample sizes must be 
sufficiently large to allow for adequate extraction of 
generalizable interactions among input variables and 
outcome and to allow for suitable model training and 
validation. Class imbalance has to be recognized and 
adjusted for. Missing data has to be reported and, if 
necessary, imputed using state-of-the-art methods. 
Trained models should not be clinically expected to 
extrapolate to patients with vastly differing 
characteristics. Finally, in binary classification 
problems, the cutoff to transform the predicted 
probabilities into a dichotomous outcome should be 
reported and set according to the goal of the clinical 
prediction model.  
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Abstract 
This section goes through all the steps required to train and validate a simple, machine learning-based clinical prediction 
model for any binary outcome, such as for example the occurrence of a complication, in the statistical programming 
language R. To illustrate the methods applied, we supply a simulated database of 10 000 glioblastoma patients who 
underwent microsurgery, and predict the occurrence of 12-month survival. We walk the reader through each step, 
including import, checking, and splitting of datasets. In terms of preprocessing, we focus on how to practically 
implement imputation using a k-nearest neighbor algorithm, and how to perform feature selection using recursive 
feature elimination. When it comes to training models, we apply the theory discussed in Parts I to III on a generalized 
linear model, a generalized additive model, a stochastic gradient boosting machine, a random forest, and a naïve Bayes 
classifier. We show how to implement bootstrapping and to evaluate and select models based on out-of-sample error. 
Specifically for classification, we discuss how to counteract class imbalance by using upsampling techniques. We discuss 
how the reporting of a minimum of accuracy, area under the curve (AUC), sensitivity, and specificity for discrimination, 
as well as slope and intercept for calibration - if possible alongside a calibration plot - is paramount. Finally, we explain 
how to arrive at a measure of variable importance using a universal, AUC-based method. We provide the full, 
structured code, as well as the complete glioblastoma survival database for the readers to download and execute in 
parallel to this section. 
 
Keywords: machine learning; clinical prediction model; prediction; prognosis; machine intelligence; artificial intelligence
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Introduction 
Predictive analytics are currently by far the most 
common application of machine learning in 
neurosurgery [3, 4, 23, 24], although the potential of 
machine learning techniques for other applications such 
as natural language processing, medical image 
classification, radiomic feature extraction, and many 
more should definitely not be understated.[7, 13, 17, 
18, 22, 28, 30 32] The topic of predictive analytics also 
uniquely lends itself to introducing machine learning 
methods due to its relative ease of implementation. 
Thus, we chose to specifically focus on predictive 
analytics as the most popular application of machine 
learning in neurosurgery. This section of the series is 
intended to demonstrate the programming methods 
required to train and validate a simple, machine 
learning-based clinical prediction model for any binary 
endpoint. Prediction of continuous endpoints 
(regression) will be covered in Part V. 
We focus on the statistical programming language 
R[16], as it is freely available and widely regarded as 
the state-of-the-art in biostatistical programming. 
Other programming languages such as Python are 
certainly equally suited to the kind of programming 
introduced here. While we elucidate all necessary 
aspects of the required code, a basic understanding of 
R is thus required. Basic R courses are offered at many 
universities around the world, as well as through 
numerous media online and in print. We highly 
recommend that users first make themselves familiar 
with the programming language before studying this 
section. Python is another programming language often 
used in machine learning. The same general principles 
and pipeline discussed here can be applied in Python to 
arrive at a prediction model.  
At this point we again want to stress that this section 
is not intended to represent a single perfect method 
that will apply to every binary endpoint, and to every 
data situation. Instead, this section represents one 
possible, generalizable methodology, that incorporates 
most of the important aspects of machine learning and 
clinical prediction modelling.  
To illustrate the methods applied, we supply a 
nts who 
underwent microsurgery, and predict the occurrence of 
12-month survival. Table 1 provides an overview over 
the glioblastoma database. We walk the reader through 
each step, including import, checking, splitting, 
imputation, and pre-processing of the data, as well as 
variable selection, model selection and training, and 
lastly correct evaluation of discrimination and 
calibration. Proper visualization and reporting of 
machine learning-based clinical prediction models for 
binary endpoints are also discussed. 
The centerpiece of this section is the provided R code 
(Supplement 1), which is intended to be used in 
combination with the provided glioblastoma database 
(Supplement 2). When executed correctly and in 
parallel with , the code will 
output the same results as those achieved by the 
authors, which allows for immediate feedback. The R 
code itself is numbered in parallel to this section, and 
also contains abundant explanations which enable a 
greater understanding of the functions and concepts 
that are necessary to succeed in generating a robust 
model. Finally, the code is intended as a scaffold upon 
which readers can build their own clinical prediction 
models for binary classification, and can easily be 
modified to do so for any dataset with a binary 
outcome. 
 
1. Setup and Pre-Processing Data 
1.1 R Setup and Package Installation 
Installing the most recent version of R (available at 
https://cran.r-project.org/) as well as the RStudio 
graphic user interface (GUI) (available at 
https://rstudio.com/products/rstudio/download/) is 
recommended.[16] A core strength of the R 
programming language is its wide adoption, and thus 
the availability of thousands of high-end, freely 
downloadable software packages that facilitate 
everything from model training to plotting graphs. 
Running pacman [19] codes in section 1.1 will 
automatically ensure that all packages necessary for 
execution of this code are installed and loaded into the 
internal memory. You will require an internet 
connection to download these packages. If you have a 
clean R installation and have no installed any of the 
packages yet, it might take multiple minutes to 
download and install all necessary data. The script also 
gives you the option to update your R installation, 
should you desire to do so. 
 
1.2 Importing Data 
Generally, it is easiest to prepare your spreadsheet in 
the following way for machine learning: First, ensure 
that all data fields are in numerical form. That is, both 
continuous and categorical variables are reported as 
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numbers. We recommend formatting binary 
(dichotomous) categorical variables (i.e. male gender) 
as 0 and 1, and categorical variables with multiple 
levels (i.e. tumor type [Astrocytoma, Glioblastoma, 
Oligodendroglioma, etc.]) as 1, 2, 3, and so forth, 
instead of as strings (text). Second, we recommend 
always placing your endpoint of interest in the last 
column of your spreadsheet. The Glioblastoma dataset 
that is provided is already correctly formatted. To 
import the data from the Glioblastoma database in 
Microsoft Excel (Supplement 2), run the code in 
section 1.2. For R to find the Glioblastoma database on 
your computer, you can either store the .xlsx file in the 
same folder as the R script, or you have to manually 
enter the path to the .xlsx file, as demonstrated in 
Figure 1. You could also 
the dataset. 
 
1.3 Check the Imported Data 
structure. We see that all 22 variables are correctly 
imported, but that they are all currently handled by R 
as numerical 
are categorical and should thus be handled in R as 
 An overview of the variables in the 
Glioblastoma database is provided in Table 1. 
 
1.4  Reformat Categorical Variables 
To reformat all categorical va
Lastly, the binary endpoint of interest 
should be internally labelled as 
reformatting. 
 
1.5 Remove Unnecessary Columns  
Your imported data may contain extra columns with 
variables that are irrelevant to the current 
classification problem, such as patient numbers, names, 
or other endpoints. The latter is the case in the 
Glioblastoma database: The 21st column contains the 
binary endpoint of interest 
this redundant variable in would lead to data leakage  
variable and extrapolate 
from it, without actually learning any features. 
Columns can be removed from a R dataframe by 
specifying the column number to be removed. 
st column of the 
database, and can thus be removed by applying the 
- df[,-  
 
1.6 Enable Multicore Processing 
If you are working on a machine with multiple central 
processing unit (CPU) cores, you can enable parallel 
computing for some functions in R. Using the code in 
section 1.6, create a computational cluster by entering 
the number of cores you want to invest into model 
development.[15] The default is set to 4, which is 
nowadays a common number of CPU cores. 
 
1.7 Partition the Data for Training and Testing 
Figure 2 illustrates the procedure. To randomly split 
the data into 80% for training an 20% for testing 
(internal validation), we first set a random seed, such 
number. Setting seeds initializes random functions in a 
constant way, and thus enables reproducibility. 
Subsequently, we randomly sample 80% of patients and 
same 
two newly partitioned sets are shuffled, and the two 
sets are checked for an approximately equal 
distribution of the binary endpoint using the 
of patients who survived for at least twelve months.  
 
1.8 Impute Missing Data 
The glioblastoma database contains no missing data, as 
[29] will let you know. 
However, should you encounter missing data, this code 
block should automatically impute missing data using a 
k-nearest neighbor (KNN) algorithm.[1] It is important 
only to impute missing data within the training set, 
and to leave the test set alone. This is to prevent data 
leakage. Also, imputation can be achieved using many 
different algorithms. We elected to use a KNN imputer 
for reasons of consistency - during model training, a 
separate KNN imputer will be co-trained with the 
prediction model to impute any future missing data. 
 
1.9 Variable Selection using Recursive Feature 
Elimination 
Recursive Feature Elimination (RFE) is just one of 
various methods for variable selection (c.f. Part II for 
further explanation). In this example, we apply RFE 
(Figure 3) due to its relative simplicity, 
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generalizability, and reproducibility. Because random 
functions are involved, seeds need to be set. A naïve 
Bayes classifier is selected, and bootstrap resampling 
with 25 repetitions is used to ensure generalizability of 
the 
function[14], the number of combined variables that are 
to be assessed can be limited. As we have 20 
independent variables, we choose to limit the search for 
the optimal number and combination of variables to 
results of the RFE procedure can be illustrated 
(Figure 4), and it is clear that a combination of 13 
variables led to the highest performance. The selected 
 These 13 
subsequently reduced to 14 columns.  
 
1.10  Get a Final Overview of the Data 
Before diving directly into model training, it is 
advisable to look over the training and test set using 
the independent variables and the endpoint. 
 
2. Model Training 
2.1 Setting up the Training Structure 
Now that the data are prepared, training of the 
different models can be initiated. In this example, we 
elected to train five different algorithms to predict 
binary 12-month survival: Logistic regression[12] 
(generalized linear models, GLM), random forests[2] 
(RF), stochastic gradient boosting machines[9] (GBM), 
generalized additive models[11] (GAM),  and naïve 
Bayes classifiers[21] (NB). A brief overview of the five 
different models is provided in Table 2. We 
specifically refrained from using more complex models, 
such as neural networks, due to their inherently 
decreased interpretability and because they are more 
prone to overfitting on the relatively simple, clinical 
data used in this example.[8] All five models are 
trained sequentially and in a similar way using a 
universal wrapper tha
package.[14] Hyperparameters  if available  are tuned 
automatically. To prevent overfitting, bootstrap 
resampling with 25 repetitions is chosen in this 
example (Figure 5).[25] However, 5-fold cross 
validation could also easily be implemented (c.f. Part 
V). To adjust for any potential class imbalance (c.f. 
Part III), random upsampling is implemented by 
minority oversampling (SMOTE) could also be used 
[5, 27] The current Glioblastoma 
dataset is however without class imbalance, as short-
term and longer-term survivors are approximately 
equally common. 
 
2.2 Model Training 
The procedure (Figure 5) is equivalent for all five 
models (Sections 2.2.1 to 2.2.5). First, a seed is set to 
initialize the random number generator in a 
reproducible way. Subsequently, the algorithm to be 
ethod  the first 
hosen. 
on the complexity and of the hyperparameters: GLM 
has no hyperparameters, so a low value is specified. We 
specify that the parameters and hyperparameters are to 
be optimized according to area under the curve (AUC, 
m -
trained for future missing data (preProcess = 
it may take some 
minutes for all resamples to finish training. The red 
will be present for as long as the model is training. 
Subsequently, a confusion matrix (conf) is generated, 
along with some other metrics that allow evaluation of 
and a calibration plot is generated using the 
[10] Finally, the model 
specifications and resampled training performance are 
function for potential further use. 
 
After completion of training the GLM (Section 2.2.1), 
the same procedure is repeated for the RF (Section 
2.2.2), GBM (Section 2.2.3), GAM (Section 2.2.4), and 
NB (Section 2.2.5) models. 
 
3. Model Evaluation and Selection 
3.1 Model Training Evaluation 
As soon as all five models have been trained, their 
performance on the training data can be compared. 
The final model should be selected based upon training 
data only. Criteria for clinical prediction model 
selection may include discrimination and calibration on 
the training set, as well as the degree of interpretability 
of the algorithm. Section 3.1 compiles the results of all 
five models, and allows their comparison in terms of 
discrimination (AUC, accuracy, sensitivity, specificity, 
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positive predictive value (PPV), negative predictive 
value (NPV), F1 score) and calibration (intercept and 
slope) metrics.[26] The code in this section will also 
allows graphical comparison of the five models. If you 
have executed all parts of the script correctly up to 
this point, you will be presented with a plot that is 
identical to Figure 6. In this plot, we see that  while 
all models performed admirably  the GLM and GAM 
had the highest discrimination metrics. Models perform 
well if these discrimination measures approach 1. In 
addition, while all absolute values of intercept were 
very low, not all models had excellent calibration 
slopes. A perfectly calibrated model has an intercept of 
0.0 and a slope of 1.0. Only the GLM and GAM had 
virtually perfect slopes. As both algorithms are highly 
interpretable, the GLM and the GAM both would 
make fine options for a final model. In this example, we 
elected to carry on with the GAM. 
 
3.2 Select the Final Model 
The fully trained GAM model was previously stored as 
model is 
and its training evaluation is renamed 
 You can choose any other model by 
replacing these two terms with the corresponding 
objects from section 2.2. 
 
3.3 Internal Validation on the Test Set 
For the first time since partitioning the original 
Glioblastoma database, the 20% of patients allocated 
to the test set are now used to internally validate the 
final model. First, a prediction is made on the test set 
Of 
note, during prediction with the GAM on the test set, 
you will encounter warning messages indicating that 
extrapolation took place. These warning messages are 
not to be considered as errors, but as informative 
warnings indicating that some patients in the test set 
had characteristics that were outside of the bounds 
encountered by the GAM during training. GAMs rely 
on local regression, which makes extrapolation to 
extreme input values problematic. This is discussed in 
some more detail in Part III. 
 
The predicted probabilities for the entire test set are 
then contrasted with the actual class labels from the 
endpoint (test$TwelveMonths) to arrive at an AUC 
value.[20] Subsequently, the predicted probabilities are 
converted into binary predictions using 
predicted probabilities over 0.50 are counted as positive 
predictions (yes), and vice versa. This cutoff for binary 
classification can be changed to different values, 
changing sensitivity and specificity of the clinical 
prediction model. However, the decision to do so must 
be based solely on the training data, and thus already 
be taken before evaluation of the test set  otherwise, a 
clean assessment of out-of-sample error through 
internal validation is not possible anymore. This is 
discussed in some more detail in Part III. However, in 
most cases and especially with well-calibrated models, a 
standard cutoff of 0.50 is appropriate.  
Subsequently, discrimination and calibration are 
calculated in the same way as previously. Using 
viewed. Performance that is on par with or slightly 
worse than the training performance usually indicates a 
robust, generalizable model. Performance that is 
relevantly worse than the training performance 
indicates overfitting during training. These problems 
are discussed in detail in Part II. The final model can 
be saved, and will be available as 
imported back into R at a later date.  
 
If you end up with the same performance metrics for 
the final GAM as in Table 3, you have executed all 
steps correctly. 
 
4. Reporting and Visualization  
When generating clinical prediction models and 
publishing their results, there is a minimum set of 
information that ought to be provided to the reader. 
First, the training methods and exact algorithm type 
should be reported, if possible along with the code that 
was used for training. Second, the characteristics of the 
cohort that was used for training should be provided, 
such as in Table 1. If multiple cohorts are combined or 
used for external validation, the patient characteristics 
should be reported in separate. Discrimination and 
calibration must be reported. There are countless 
metrics to describe calibration and discrimination of 
prediction models. The bare minimum that should be 
reported for a binary prediction model probably 
consists of AUC, accuracy, sensitivity, specificity, PPV, 
and NPV, along with calibration intercept and slope. 
The F1 score can also be provided. A calibration plot 
should also be provided for binary prediction models. 
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Lastly, whenever feasible, an attempt at interpreting 
the model should be made. For example, logistic 
regression (GLM) models produce odds ratios, and 
GAMs can produce partial dependence values. 
However, there are also universal methods to generate 
variable importance measures that can apply to most 
binary prediction models, usually based on AUC, which 
we present below. To simplify reporting, this final 
section helps compile all these data required for 
publication of clinical prediction models. For further 
information on reporting standards, consult the 
transparent reporting of a multivariable prediction 
model for individual prognosis or diagnosis (TRIPOD) 
checklist.[6] 
 
4.1 Compiling Training Performance 
The resampled training performance in terms of 
discrimination and calibration can be printed using 
include AUC, accuracy, sensitivity (recall), specificity, 
PPV (precision), NPV, F1 score, intercept, and slope. 
Subsequently, a calibration plot is generated for the 
 
 
4.2 Compiling Internal Validation Performance 
Similarly, the performance on the test set (internal 
validation) can be recapitulated, and a calibration plot 
produced (analogous to Figure 7). 
 
4.3 Assessing Variable Importance 
d for 
estimation of variable importance based on AUC is 
executed, and results in a list of values ranging from 0 
to 100, with 100 indicating the variable that 
contributed most strongly to the predictions, and vice 
versa. Finally, generates a variable 
importance plot that can also be included in 
publication of clinical prediction models (c.f. Part V). 
 
Conclusion 
This section presents one possible and standardized 
way of developing clinical prediction models for binary 
endpoints. Proper visualization and reporting of 
machine learning-based clinical prediction models for 
binary endpoints are also discussed. We provide the 
full, structured code, as well as the complete 
Glioblastoma survival database for the readers to 
download and execute in parallel to this section. The 
methods presented can and are in fact intended to be 
extended by the readers to new datasets, new 
endpoints, and new algorithms.  
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Figures 
 
Figure 1 Code section 1.2: You can either import the Glioblastoma database by keeping its .xlsx file in the same folder 
as the R script (A). Alternatively, you may have to find the path /database.xlsx  to the .xlsx file and 
enter it as a string, i.e. between quotes (B). Lastly, you could also use the graphic user interface of RStudio to import 
the file. 
 
 
Figure 2 Code section 1.7: This section illustrates how to partition a database into training and test (internal 
validation) sets. 
 
 
Figure 3 Code section 1.9: This section illustrates the recursive feature elimination (RFE) procedure. A naïve Bayes 
classifier is chosen, along with bootstrap resampling with 25 repetitions.  
 
Figure 4 Results of the recursive feature elimination (RFE) variable election procedure. It was determined that using 
13 variables explained the highest amount of variance, as seen in the superior accuracy that was achieved with this 
number and combination of variables. 
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Figure 5 Code sections 2.1 & 2.2: First, the training structure is established: Bootstrap resampling with 25 repetitions 
is used. As a standard, random upsampling is applied to adjust for class imbalance if present. Subsequently, a logistic 
regression model (generalized linear model, GLM) is trained. All predictor variables are provided to the model, and it is 
automatically tuned for AUC. A k-nearest neighbor imputer is co-trained to impute any potential missing data in future 
predictions. Subsequently, discrimination and calibration are assessed, and the final model information and resampled 
training performance are printed. 
 
Figure 6 Graphical comparison of discrimination (left) and calibration (right) metrics (Code section 3.1). The GLM 
and GAM both exhibited the highest discrimination measures, with very low absolute intercept values and almost 
perfect slopes approaching 1. 
 
Figure 7 Calibration plot for the final GAM, demonstrating its calibration on the test set (internal validation). The 
calibration curve closely approximates the diagonal line, indicating excellent calibration. 
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Tables 
Table 1  Values are 
provided as means and standard deviations or as numbers and percentages.  
Variable Name Description Value 
Survival Overall survival from diagnosis in months 12.1 ± 3.1 
TwelveMonths Patients who survived 12 months or more from diagnosis 5184 (51.8%) 
IDH IDH mutation present 4136 (41.4%) 
MGMT MGMT promoter methylated 5622 (56.2%) 
TERTp TERTp mutation present 5108 (51.1%) 
Male Male gender 4866 (48.7%) 
Midline Extension of the tumor into the midline 2601 (26.0%) 
Comorbidity Presence of any systemic comorbidity such as diabetes, coronary 
heart disease, chronic obstructive pulmonary disease, etc. 
5135 (51.4%) 
Epilepsy Occurrence of an epileptic seizure  3311 (33.1%) 
PriorSurgery Presence of prior cranial surgery 5283 (52.8%) 
Married Positive marriage status 5475 (54.8%) 
ActiveWorker Patient is actively working, i.e. not retired, student, out of work, 
etc. 
5459 (54.6%) 
Chemotherapy Patients who received chemotherapy for glioblastoma 4081 (40.8%) 
HigherEducation Patients who received some form of higher education 4209 (42.1%) 
Caseload Yearly glioblastoma microsurgery caseload at the treating center 165.0 ± 38.7 
Age Patient age at diagnosis in years 66.0 ± 6.2 
RadiotherapyDose Total radiotherapy absorbed dose in Gray  24.8 ± 6.7 
KPS Karnofsky Performance Scale 70.5 ± 8.0 
Income Net yearly household income in US dollars  
Height Patient body height in cm 174.6 ± 6.7 
BMI Deviation of body mass index from 25; in kg/m2 0.02 ± 1.0 
Size Maximum tumor diameter in cm 2.98 ± 0.55 
 
 
 
 
Table 2 Overview of the five models that were employed. 
Model 
caret::train() 
input 
Package Suitability Hyperparameters 
Generalized Linear Model glm stats Classification, Regression None 
Random Forest rf randomForest Classification, Regression 
mtry (number of variables at each tree 
node) 
Stochastic Gradient Boosting gbm gbm Classification 
n.trees (number of trees), interaction.depth 
(maximum nodes per tree), shrinkage 
(learning rate), n.minobsinnode (minimum 
number of patients per terminal node) 
Generalized Additive Model gamLoess gam Classification, Regression 
span (smoothing span width), degree 
(degree of polynomial) 
Naïve Bayes Classifier nb klaR Classification 
fL (Laplace correction factor), usekernel 
(normal or kernel density estimate), adjust 
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Table 3 Performance metrics of the binary classification model (generalized additive model; GAM) for 12-month 
glioblastoma survival. The difference in performance among training and testing is minimal, demonstrating a lack of 
overfitting at internal validation. 
Metric Cohort 
 
Training 
(n = 8000) 
Internal Validation 
(n = 2000) 
Discrimination   
AUC 0.926 0.922 
Accuracy 0.839 0.847 
Sensitivity 0.839 0.848 
Specificity 0.839 0.846 
PPV 0.849 0.848 
NPV 0.830 0.826 
F1 Score 0.844 0.843 
Calibration   
Intercept 0.074 0.039 
Slope 1.004 0.961 
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Abstract 
This section goes through the steps required to train and validate a simple, machine learning-based clinical prediction 
model for any continuous outcome, such as for example survival or a continuous outcome scale after surgery, in the 
statistical programmi
glioblastoma patients who underwent microsurgery, and predict survival from diagnosis in months. We walk the reader 
through each step, including import, checking, splitting of data. In terms of preprocessing, we focus on how to practically 
implement imputation using a k-nearest neighbor algorithm. We also illustrate how to select features based on recursive 
feature elimination, and how to use k-fold cross validation. When it comes to training models, we apply the theory 
discussed in Parts I to III on a generalized linear model, a generalized additive model, a random forest, a ridge regressor, 
and a Least Absolute Shrinkage and Selection Operator (LASSO) regressor. Specifically for regression, we discuss how to 
evaluate root mean square error (RMSE), mean average error (MAE), and the R2 statistic, as well as how a quantile-
quantile plot can be used to assess the performance of the regressor along the spectrum of the outcome variable, similarly 
to calibration when dealing with binary outcomes. Finally, we explain how to arrive at a measure of variable importance 
using a universal, nonparametric method. We provide the full, structured code, as well as the complete glioblastoma 
survival database for the readers to download and execute in parallel to this section. 
 
Keywords: machine learning; clinical prediction model; prediction; prognosis; machine intelligence; artificial intelligence   
Kernbach & Staartjes Machine learning-based clinical prediction modeling Part V 
 
2 
 
Introduction 
In the neurosurgical literature, applications of machine 
learning for clinical prediction modeling are by far the 
most common [3, 4, 18, 19]. The topic of predictive 
analytics also uniquely lends itself to introducing 
machine learning methods due to its relative ease of 
implementation. Still, we chose to specifically focus on 
predictive analytics as the most popular application of 
machine learning in neurosurgery. Nonetheless, the great 
potential of machine learning methods in fields other 
than prediction modeling, such as e.g. natural language 
processing, medical image classification, radiomic feature 
extraction, and many more must not go unmentioned.[6, 
10, 14, 15, 17, 22, 24 26] In clinical predictive analytics, 
those models concerned with prediction of continuous 
endpoints (e.g. survival in months) as opposed to binary 
endpoints (e.g. occurrence of a complication) are coined 
regressors. Regression problems, in contrast to 
classification problems, require different methodology, 
different algorithms, and different evaluation and 
reporting strategies. 
Whereas Part IV laid out the details of generating 
binary prediction models, this section of the series is 
intended to demonstrate the programming methods 
required to train and validate a simple, machine 
learning-based clinical prediction model for any 
continuous endpoint. Many concepts and parts of the 
code have already been discussed in more detail in Part 
IV, and this part will focus on the differences to 
predicting binary endpoints. For a better understanding 
of the methods presented herein, Part IV should thus be 
studied first. 
We focus on the statistical programming language R[13], 
as it is freely available and widely regarded as the state-
of-the-art in biostatistical programming. While we 
elucidate all necessary aspects of the required code, a 
basic understanding of R is thus required. Basic R 
courses are offered at many universities around the 
world, as well as through numerous media online and in 
print. We highly recommend that users first make 
themselves familiar with the programming language 
before studying this section. 
At this point we again want to stress that this section is 
not intended to represent a single perfect method that 
will apply to every continuous endpoint, and to every 
data situation. Instead, this section represents one 
possible, generalizable methodology, that incorporates 
most of the important aspects of machine learning and 
clinical prediction modelling.  
To illustrate the methods applied, we supply a simulated 
microsurgery, and predict the occurrence of 12-month 
survival. Table 1 provides an overview over the 
glioblastoma database. We walk the reader through each 
step, including import, checking, splitting, imputation, 
and pre-processing of the data, as well as variable 
selection, model selection and training, and lastly correct 
evaluation of the regression model. Proper reporting is 
also discussed. 
The centerpiece of this section is the provided R code 
(Supplement 1), which is intended to be used in 
combination with the provided glioblastoma database 
(Supplement 2). When executed correctly and in 
the same results as those achieved by the authors, which 
allows for immediate feedback. The R code itself is 
numbered in parallel to this section, and also contains 
abundant explanations which enable a greater 
understanding of the functions and concepts that are 
necessary to succeed in generating a robust model. 
Finally, the code is intended as a scaffold upon which 
readers can build their own clinical prediction models for 
regression, and can easily be modified to do so for any 
dataset with a continuous outcome. 
 
1. Setup and Pre-Processing Data 
Sections 1.1 to 1.3 are identical to those required for 
classification problems, and are thus covered in Part 
IV.[16] Thus, we kindly ask the reader to consult Part 
IV for further clarification on R setup, package loading, 
importing data, and checking the formatting of the 
imported data. 
 
1.4 Reformat Categorical Variables 
reformatting. 
1.5 Remove Unnecessary Columns  
Your imported data may contain extra columns with 
variables that are irrelevant to the current regression 
problem, such as patient numbers, names, or other 
endpoints. The latter is the case in the Glioblastoma 
database: The 22nd column contains the variable 
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redundant variable in would lead to data leakage  the 
variable and extrapolate some parts of our endpoint 
features. Columns can be removed from a R dataframe 
by specifying the column number to be removed. 
nd column of the 
database, and can thus be removed by applying the 
- df[,-  
 
1.6 Enable Multicore Processing 
If you are working on a machine with multiple central 
processing unit (CPU) cores, you can enable parallel 
computing for some functions in R. Using the code in 
section 1.6, create a computational cluster by entering 
the number of cores you want to invest into model 
development.[12] The default is set to 4, a common 
number of CPU cores in 2020. 
 
1.7 Partition the Data for Training and Testing 
Figure 1 illustrates the procedure. To randomly split 
the data into 80% for training an 20% for testing 
(internal validation), we first set a random seed, such as 
Setting seeds initializes random functions in a constant 
way, and thus enables reproducibility. Subsequently, we 
randomly sample 80% of patients and allocate them to 
itioned 
sets are shuffled, and the two sets are checked for an 
approximately equal distribution of the continuous 
histograms 
show a very similar distribution, both with mean 
survival of around 12 months.  
 
1.8 Impute Missing Data 
The glioblastoma database contains no missing data, as 
[23] will let you know. 
However, should you encounter missing data, this code 
block should automatically impute missing data using a 
k-nearest neighbor (KNN) algorithm.[1] It is important 
only to impute missing data within the training set, and 
to leave the test set alone. This is to prevent data 
leakage. Also, imputation can be achieved using many 
different algorithms. We elected to use a KNN imputer 
for reasons of consistency - during model training, a 
separate KNN imputer will be co-trained with the 
prediction model to impute any future missing data. 
1.9 Variable Selection using Recursive Feature 
Elimination 
Recursive Feature Elimination (RFE) is just one of 
various methods for variable selection (c.f. Part II for 
further explanation). In this example, we apply RFE 
(Figure 2) due to its relative simplicity, 
generalizability, and reproducibility. Because random 
functions are involved, seeds need to be set. A linear 
model is selected as the regressor, and bootstrap 
resampling with 25 repetitions is used to ensure 
 [11], the number of 
combined variables that are to be assessed can be 
limited. As we have 20 independent variables, we choose 
to limit the search for the optimal number and 
combination of variables to between 10 and 20. The 
s of the RFE 
procedure can be illustrated (Figure 3), and it is clear 
that a combination of 16 variables led to the highest 
performance. The selected variables are stored in 
training set is subsequently reduced to 17 columns.  
 
1.10  Get a Final Overview of the Data 
Before diving directly into model training, it is advisable 
to look over the training and test set using the 
 the correctness of the 
independent variables and the endpoint. 
 
2 Model Training 
2.5 Setting up the Training Structure 
Now that the data are prepared, training of the different 
models can be initiated. In this example, we elected to 
train five different algorithms to predict continuous 
survival in months: Linear regression using a generalized 
linear model (GLM), random forests [2] (RF), 
generalized additive models [8] (GAM), Least Absolute 
Shrinkage and Selection Operator (Lasso) regression [9], 
and ridge regression [9]. A brief overview of the five 
different models is provided in Table 2. We specifically 
refrained from using more complex models, such as 
neural network regressors, due to their inherently 
decreased interpretability and because they are more 
prone to overfitting on the relatively simple, clinical data 
used in this example.[7] All five models are trained 
sequentially and in a similar way using a universal 
[11] 
Hyperparameters  if available  are tuned 
automatically. To prevent overfitting, 5-fold cross 
validation was chosen as resampling technique in this 
example (Figure 4).[20] However, bootstrap resampling 
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with 25 repetitions could also easily be implemented (c.f. 
Part IV).  
 
2.6 Model Training 
The procedure (Figure 4) is equivalent for all five 
regressors (Sections 2.2.1 to 2.2.5). First, a seed is set to 
initialize the random number generator in a reproducible 
way. Subsequently, the algorithm to be used is specified 
 the first model to be trained 
is a linear 
of the hyperparameters: GLM has no hyperparameters, 
so a low value is specified. We specify that the 
parameters and hyperparameters are to be optimized 
according to root mean square error (RMSE, metric = 
RMSE -trained for 
inputs are automatically centered and scaled by the 
cified 
top right of the RStudio console will be present for as 
long as the model is training. Subsequently, the 
resampled  performance metrics RMSE, mean average 
error (MAE), and R2 are calculated. Finally, the model 
specifications and resampled training performance are 
function for potential further use. 
 
After completion of training the GLM (Section 2.2.1), 
the same procedure is repeated for the GAM (Section 
2.2.2), Lasso regressor (Section 2.2.3), ridge regressor 
(Section 2.2.4), and RF (Section 2.2.5) models. 
 
3 Model Evaluation and Selection 
3.5 Model Training Evaluation 
As soon as all five models have been trained, their 
performance on the training data can be compared. The 
final model should be selected based upon training data 
only. Criteria for clinical prediction model selection may 
include discrimination and calibration on the training 
set, as well as the degree of interpretability of the 
algorithm. Section 3.1 compiles the results of all five 
models, and allows their comparison in terms of RMSE, 
MAE, and R2. The code in this section will also open a 
graphical comparison of the five models. If you have 
executed all parts of the script correctly up to this point, 
you will be presented with a plot that is identical to 
Figure 5. In this plot, we see that  while all models 
performed admirably  the GLM (linear model), GAM, 
and ridge regressor had the lowest error values (RMSE 
and MAE). Models perform well if these error values 
approach 0. In addition, all models except for the RF 
had very high R2 values, indicating high correlation of 
predicted with actual survival values. The R2 value, 
taken together with quantile-quantile plots that will be 
demonstrated further on, can serve a role similar to 
calibration measures in binary classification models  
namely, as an indication of how well the predicted values 
correspond to the actual values over the spectrum of 
survival lengths.[21] As all of the best-performing 
algorithms are highly interpretable, the GLM, GAM, 
and ridge regressor would all make fine options for a final 
model. In this example, we elected to carry on with the 
ridge regressor. 
 
3.6 Select the Final Model 
The fully trained ridge regressor was previously stored 
ridgefit
RIDGE ridge regressor 
model is selected as the final model, it is renamed 
ion is renamed 
replacing these two terms with the corresponding objects 
from section 2.2. 
 
3.3 Internal Validation on the Test Set 
For the first time since partitioning the original 
Glioblastoma database, the 20% of patients allocated to 
the test set are now used to internally validate the final 
model. First, a prediction is made on the test set using 
survival values for the entire test set are then contrasted 
with the actual survival values from the endpoint 
(test$Survival) to arrive at error values. Using 
viewed. Performance that is on par with or slightly worse 
than the training performance usually indicates a robust, 
generalizable model. Performance that is relevantly 
worse than the training performance indicates 
overfitting during training. These problems are discussed 
in detail in Part II. The final model can be saved, and 
will be available 
models can be imported back into R at a later date.  
 
If you end up with the same performance metrics for the 
final ridge regressor as in Table 3, you have executed 
all steps correctly. 
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4 Reporting and Visualization  
When generating clinical prediction models and 
publishing their results, there is a minimum set of 
information that ought to be provided to the reader. 
First, the training methods and exact algorithm type 
should be reported, if possible along with the code that 
was used for training. Second, the characteristics of the 
cohort that was used for training should be provided, 
such as in Table 1. If multiple cohorts are combined or 
used for external validation, the patient characteristics 
should be reported in separate. For regression models, a 
minimum of RMSE, MAE, and R2 should be reported 
for both training and testing performance. There are 
countless other metrics to describe regression 
performance of clinical prediction models. Lastly, 
whenever feasible, an attempt at interpreting the model 
should be made. For example, logistic regression (GLM) 
models produce odds ratios, and GAMs can produce 
partial dependence values. However, there are also 
universal methods to generate variable importance 
measures that can apply to most regression models, 
which we present below. To simplify reporting, this final 
section helps compile all these data required for 
publication of clinical prediction models. For further 
information on reporting standards, consult the 
transparent reporting of a multivariable prediction 
model for individual prognosis or diagnosis (TRIPOD) 
checklist.[5] 
 
4.5 Compiling Training Performance 
The resampled training performance can be printed 
produced include RMSE, MAE, and R2. Subsequently, a 
quantile-quantile (Q-Q) plot is generated for the training 
qqplot  A quantile-quantile 
plot plots quantiles of predicted values against quantiles 
of true survival values, and can thus be used to judge 
how a regressor performs over the wide span of survival 
values (short-term and long-term survivors). 
4.6 Compiling Internal Validation Performance 
Similarly, the performance on the test set (internal 
validation) can be recapitulated, and a quantile-quantile 
plot produced (analogous to Figure 6). 
 
4.7 Assessing Variable Importance 
estimation of variable importance based on AUC is 
executed, and results in a list of values ranging from 0 
to 100, with 100 indicating the variable that contributed 
most strongly to the predictions, and vice versa. Finally, 
 
can also be included in publication of clinical prediction 
models (See Figure 7). 
 
Conclusion 
This section presents one possible and standardized way 
of developing clinical prediction models for regression 
problems such as patient survival. Proper visualization 
and reporting of machine learning-based clinical 
prediction models for continuous endpoints are also 
discussed. We provide the full, structured code, as well 
as the complete Glioblastoma survival database for the 
readers to download and execute in parallel to this 
section. The methods presented can and are in fact 
intended to be extended by the readers to new datasets, 
new endpoints, and new algorithms.  
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Figures 
 
Figure 1 Code section 1.7: This section illustrates how to partition a database into training and test (internal validation) 
sets. 
 
 
Figure 2 Code section 1.9: This section illustrates the recursive feature elimination (RFE) procedure. A generalized linear 
model (GLM) is chosen as the regressor, along with bootstrap resampling with 25 repetitions. 
 
Figure 3 Results of the recursive feature elimination (RFE) variable election procedure. It was determined that using 16 
variables explained the highest amount of variance, as seen in the low RMSE that was achieved with this number and 
combination of variables. 
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Figure 4 Code sections 2.1 & 2.2: First, the training structure is established: 5-fold cross validation is used. Subsequently, 
a linear regression model (generalized linear model, GLM) is trained. All predictor variables are provided to the model, 
and it is automatically tuned for root mean square error (RMSE). A k-nearest neighbor imputer is co-trained to impute 
any potential missing data in future predictions. Subsequently, performance is assessed, and the final model information 
and resampled training performance are printed. 
Figure 5 Graphical comparison of root mean square error (RMSE) and mean average error (MAE) to the left, and R2 to 
the right (Code section 3.1). The linear model, the LASSO model, and the ridge regressor all exhibited similarly low error 
values (RMSE and MAE), and all three achieved high R2 values. 
 
 
Figure 6 Quantile-Quantile plot for the final ridge regressor, demonstrating the relationship between predicted survival 
values and actual survival in months on the test set (internal validation). The curve can be interpreted similarly to a 
calibration curve seen for binary classification models. The curve closely approximates a diagonal line, indicating excellent 
performance for both short-term and long-term survivors. 
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Figure 7 Variable importance of the final model based on a nonparametric, model-independent method. The importance 
metrics are scaled from 0 to 100. 
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Tables 
Table 1 
as means and standard deviations or as numbers and percentages.  
Variable Name Description Value 
Survival Overall survival from diagnosis in months 12.1 ± 3.1 
TwelveMonths Patients who survived 12 months or more from diagnosis 5184 (51.8%) 
IDH IDH mutation present 4136 (41.4%) 
MGMT MGMT promoter methylated 5622 (56.2%) 
TERTp TERTp mutation present 5108 (51.1%) 
Male Male gender 4866 (48.7%) 
Midline Extension of the tumor into the midline 2601 (26.0%) 
Comorbidity Presence of any systemic comorbidity such as diabetes, coronary 
heart disease, chronic obstructive pulmonary disease, etc. 
5135 (51.4%) 
Epilepsy Occurrence of an epileptic seizure  3311 (33.1%) 
PriorSurgery Presence of prior cranial surgery 5283 (52.8%) 
Married Positive marriage status 5475 (54.8%) 
ActiveWorker Patient is actively working, i.e. not retired, student, out of work, etc. 5459 (54.6%) 
Chemotherapy Patients who received chemotherapy for glioblastoma 4081 (40.8%) 
HigherEducation Patients who received some form of higher education 4209 (42.1%) 
Caseload Yearly glioblastoma microsurgery caseload at the treating center 165.0 ± 38.7 
Age Patient age at diagnosis in years 66.0 ± 6.2 
RadiotherapyDose Total radiotherapy absorbed dose in Gray  24.8 ± 6.7 
KPS Karnofsky Performance Scale 70.5 ± 8.0 
Income Net yearly household income in US dollars  
Height Patient body height in cm 174.6 ± 6.7 
BMI Deviation of body mass index from 25; in kg/m2 0.02 ± 1.0 
Size Maximum tumor diameter in cm 2.98 ± 0.55 
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Table 2 Overview of the five models that were employed. 
Model 
caret::train() 
input 
Package Suitability Hyperparameters 
Generalized Linear Model glm stats Classification, Regression None 
Random Forest rf randomForest Classification, Regression 
mtry (number of variables at each tree 
node) 
Least Absolute Shrinkage and 
Selection Operator (Lasso)  
lasso elasticnet Regression 
fraction (sum of absolute values of the 
regression coefficients) 
Ridge Regression ridge elasticnet Regression lambda (shrinkage factor)  
Generalized Additive Model gamLoess gam Classification, Regression 
span (smoothing span width), degree 
(degree of polynomial) 
 
 
 
 
Table 3 Performance metrics of the final regression model (ridge regression) for glioblastoma survival in months. The 
difference in performance among training and testing is minimal, demonstrating a lack of overfitting at internal validation. 
Metric Cohort 
 
Training 
(n = 8000) 
Internal Validation 
(n = 2000) 
Root mean square error (RMSE) 1.504 1.515 
Mean absolute error (MAE) 1.191 1.211 
R2 0.763 0.759 
 
 
 
 
 
 
 
 
 
 
Supplementary Material 
Please download the supplementary files from https://micnlab.com/files/ 
Supplement 1 R Code for binary classification of twelve-month survival of glioblastoma patients. 
Supplement 2  simulated glioblastoma patients, intended for use with the R code 
